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1.1.1 Classification of Cytomegaloviruses 
Cytomegaloviruses (CMV) are members of Herpesviridae, a family of large double stranded 
DNA viruses that infect a wide spectrum of species, including reptiles, birds and mammals. 
Members of this family share the ability to establish a life-long latency in their host. 
Herpesviridae are divided into three subfamilies named Alpha-, Beta-, and 
Gammaherpesvirinae. These are differentiated by nucleotide or predicted amino acid 
sequences. Betaherpesvirinae are characterized by genes found in the Human 
betaherpesvirus 5 (HHV-5), also known as Human cytomegalovirus (HCMV) (ICTV 2019, 
Lefkowitz et al. 2017). Betaherpesvirinae consist of four genera: Cytomegalovirus, 
Muromegalovirus, Proboscivirus and Roseolovirus. Viruses of these genera are species-
specific and exclusively infect mammals. While HCMV is a member of the genus 




Figure 1: Taxonomy of Herpesviridae. The herpesvirus family is subclassified into the Alpha-, Beta-, 
Gammaherpesvirinae. Each subfamily consists of distinct genera. Only one to three representative species are 
shown for each genus. The phylogenetic tree was created based on the latest version of the International 
Committee on Taxonomy of Viruses (ICTV 2019). Species that is investigated in this work is colored in red. 
Muromegaloviruses infect rodents and as Cytomegalovirus consist of a large genome (> 200 




(MuHV-1), also known as MCMV, and MuHV-2, known as RCMV-Maastricht (RCMV-M). 
Additionally, the two isolates RCMV-England and RCMV-Berlin have been described and 
grouped within the genus Muromegalovirus under the name MuHV-8 since 2011 (Voigt and 
Hayward 2011). 
1.1.2 Rat cytomegalovirus 
38 years ago, Bruggeman et al. isolated an infectious particle from salivary glands from rats 
(Rattus norvegicus) captured in the Netherlands (Bruggeman et al. 1982). Further 
investigations showed that the infectious particles displayed a variety of similarities to MCMV 
and HCMV, including particle size and morphology, the ability to form plaques in fibroblast 
monolayers and to induce cytomegalia, and the preference to persist in salivary glands. The 
infectious particles were confirmed to resemble a RCMV strain. Additional similarities to 
HCMV, such as the virus being excreted in urine and saliva, leukocyte-associated viremia 
and the persistence of the virus in the kidney without clinical disease, suggested that the 
isolated RCMV, named RCMV-Maastricht, could be used as a model to study CMV infections 
in humans (Bruggeman et al. 1985). During the same time another group isolated a similar 
infectious particle from Rattus norvegicus in England that exhibited characteristics 
comparable to HCMV. This virus was named RCMV-England (RCMV-E) (Priscott and Tyrrell 
1982). A few years later, analysis of genome sizes, growth characteristics and genome 
sequences revealed that these viruses represent two highly diverged species, leading to the 
classification of RCMV-M as MuHV-2 and RCMV-E as MuHV-8 (Beisser et al. 1998a, 
Ettinger et al. 2012, Geyer et al. 2015, Vink et al. 2000, Voigt et al. 2005). Whole genome 
comparison analysis revealed that MuHV-8 differs significantly from MuHV-2 in size, base 
composition and genomic content. The genome of RCMV-E has a size of 203 kbp and is 27 
kb smaller than RCMV-M. In 2015, a new infectious virus was isolated from Rattus 
norvegicus in Berlin that showed high sequence similarities to RCMV-E that was also 
classified as MuHV-8. The identification of the new MuHV-8 isolate, named RCMV-Berlin 
(RCMV-B) (Geyer et al. 2015), gave evidence that the smaller genome size of 203 kbp was 
not a result of accidental deletion by passage in cell culture as it was reported for the HCMV 
strains AD169 and Towne (Cha et al. 1996, Sinzger et al. 1999) but represents a distinct 
MuHV-8. Furthermore, it has been shown that MuHV-8 shares more sequence similarity with 
its mouse ortholog MCMV (MuHV-1) compared to its rat ortholog RCMV-M (MuHV-2) (Geyer 
et al. 2015). Despite its smaller genome size, MuHV-8 has unique genes that are not present 
in other CMVs. These genes encode homologs of the X-C Motif Chemokine Ligand 1 
(XCL1), the C-type lectin receptor (Clr) ligand and CD200 which were named vXCL1, RCTL 
and e127, respectively (Foster-Cuevas et al. 2011, Geyer et al. 2014, Voigt et al. 2007, Voigt 




strategies to adapt and broadly influence the innate and the adaptive immune systems of 
their hosts with the help of numerous genes that encode protein homologs important for 
regulating the immune response (Miller-Kittrell and Sparer 2009). In accordance with these 
findings and as it has been shown for RCTL (Voigt et al. 2007), vXCL1 and e127 might also 
interfere with the immune system. 
1.1.3 CMV structure and replication 
All CMV exhibit a common virion structure composed of an outer membrane envelope that 
takes the form of a lipid bilayer, a phosphoprotein tegument layer and an icosahedral capsid 
enclosing the linear double-stranded DNA (Figure 2). The outer membrane bears several 
glycoproteins that are necessary for viral attachment. The particle size ranges from 150 to 
200 nm. Their genome size varies from 203 kb for MuHV-8 to 241 kb for Panine herpesvirus 
2, also known as Chimpanzee Cytomegalovirus (CCMV) (Davison et al. 2003, Ettinger et al. 
2012). 
 
Figure 2: Electron microscopic image of RCMV-E. Bar = 200 nm. Image taken by Lars Möller, Robert Koch 
Institute. 
CMV infect a broad range of host cells, including epithelial and endothelial cells, fibroblasts, 
monocytes/macrophages and dendritic cells (DC) (Sinzger et al. 2008). It has been shown 
that latent infection is associated with cells of the monocyte series, including macrophages 
and DC (Jarvis and Nelson 2002). The attachment of CMV occurs through interaction of 
specific viral glycoprotein complexes, e.g., gH, gL and MCK-2 in the case of MCMV, with 
various host cell receptors which can differ among cell types (Wagner et al. 2013, Wang and 
Shenk 2005). After fusion of the virus’ lipid bilayer with the host membrane the viral DNA is 
released into the nucleus (Granzow et al. 1997, Sodeik et al. 1997). Viral transcription, viral 




genes follows a temporally regulated cascade with three chronological phases: immediate 
early (IE), early (E) and late (L) phase (Wathen and Stinski 1982). IE genes are the first to be 
transcribed. They function as transcription factors for early proteins, which play an essential 
role in viral replication. The late genes are transcribed last and encode structural 
components of the virion. They are necessary for virion assembly and egress. After 
nucleocapsids have formed in the nuclear factories tegumentation occurs in the cytoplasm 
followed by budding into vesicles of the trans-Golgi network and exocytosis (Mettenleiter 
2002, Novoa et al. 2005). Like all Herpesviruses, CMV has the ability to establish life-long 
latency following the initial acute infection (Jarvis and Nelson 2002). During latency, no 
infectious particles are produced while the circularized DNA remains as an episome in the 
nucleoplasm. In this phase, only a few specific latency-associated genes are transcribed. 
The major sites of persistence as well as transmission of CMV are salivary glands (Campbell 
et al. 2008). 
1.2 Immune system and response to CMV infection 
The immune system is a complex interacting network that comprises an innate immunity that 
is not antigen-specific and an adaptive immunity that is antigen-specific. Key features of the 
innate immunity are the recognition of danger, triggered by pathogens or cell injury, and the 
transport of this signal to cells of the adaptive immune system (Banchereau et al. 2000). The 
interaction between the innate and the adaptive immune response plays a crucial role in the 
immune system and requires a communication platform. This is facilitated by antigen 
presenting cells (APC), including macrophages, B cells and DC. As part of the innate 
immune response APC recognize potentially dangerous particles. After intracellular 
processing, antigens are presented to cells of the adaptive immune system, including T cells.  
1.2.1 Dendritic cells and antigen presentation 
DC are highly adapted to their role as antigen-presenting cells and directing immune 
responses (Brinkman et al. 2013). DC are derived from bone marrow hematopoietic 
progenitor cells and are especially abundant in skin, mucosa and lymphoid tissues (Austyn 
1996). In contrast to macrophages, DC can leave the tissue by getting attracted to the site of 
infection. DC subsets can be distinguished based on their phenotype, location or functionality 
(Guilliams et al. 2014). In mice and humans, there are three major groups of DC: 
conventional DC 1 and 2 (cDC1 and cDC2) as well as plasmacytoid DC (pDC) (Guilliams et 
al. 2014, Naik et al. 2007). cDC process ingested peptides that can be presented to T cells, 
while pDC produce antiviral type 1 interferons (IFN- and -) to activate further immune 




Immature cDC exhibit a high phagocytic capacity. This is important for the ingestion and 
procession of antigens that are presented to T cells. Three major ways of antigen 
presentation have been characterized: the Major histocompatibility complex (MHC) class I 
pathway, the MHC class II pathway and Cross-presentation.  
The MHC class I pathway involves proteasomal processing of endogenous peptides or 
antigens that originate from the cell or from a pathogen replicating within the cell. Peptides 
derived from degraded proteins are transported via transporter associated with antigen 
processing (TAP) to the endoplasmic reticulum (ER). There, antigens are loaded on MHC 
class I and are ultimately presented to CD8+ T cells (also known as cytotoxic T lymphocytes, 
CTL). If a foreign antigen is presented, the cell that bears this antigen is getting defeated by 
the primed CTL (Vyas et al. 2008).  
In the MHC class II pathway, exogenous peptides are taken up by professional APC via 
phagocytosis, pinocytosis or receptor-mediated endocytosis. Antigens are loaded on MHC 
class II molecules within a phagosome or endosome, depending on the modes of previous 
internalization, followed by the transport to the cell surface and presentation to CD4+ T cells. 
CD4+ T cells are also known as T helper cells. They can further differentiate into T helper 
subsets that activate macrophages, B cells or cytotoxic T cells (Guermonprez et al. 2002, 
Zhu Jinfang and Paul 2010).  
The third pathway, designated as cross-presentation, exhibits parts of both the MHCI and the 
MHCII pathways. Here, exogenous antigens are loaded on MHCI molecules and presented 
to CD8+ T cells (Sigal et al. 1999). Cross-presentation can occur through a cytosolic or 
vacuolar pathway that are regulated differentially. In particular, the cytosolic cross-
presentation has two ways of antigen loading: exogenous antigens can be processed by the 
proteasome and loaded onto MHCI molecules in the ER or reimported to the phagosome 
where antigens are loaded onto MHCI (Joffre et al. 2012). During vacuolar cross-
presentation, antigens undergo phagosomal degradation followed by phagosomal loading on 






Figure 3: Antigen presentation pathways in dendritic cells (DC). DC can present antigens via MHC class I 
and MHC class II molecules to T cells. In the MHC class I pathway, peptides derived from proteins degraded in 
the cytosolic proteasome (endogenous antigens) are transported via a transporter associated with antigen 
processing (TAP) to the endoplasmic reticulum (ER), loaded onto MHCI and after vesicular transport to the cell 
surface presented to CD8+ T cells. In the MHC class II pathway exogenous antigens are loaded onto MHCII in the 
endosome, transported to the cell surface and then presented to CD4+ T cells. During cross-presentation 
exogenous antigens are loaded onto MHCI and presented to CD8+ T cells. In the cross-presentation cytosolic 
pathway exogenous antigens are transported from the phagosome to the cytosol, where they undergo proteolysis. 
Antigens can then undergo ER loading or be re-imported to the phagosome for phagosomal loading. In the 
vacuolar pathway exogenous antigens are degraded and loaded onto MHCI in the phagosome. Modified after 
(Joffre et al. 2012, Villadangos and Schnorrer 2007). 
To date, the intracellular pathways of cross-presentation are insufficiently understood. 
Nevertheless, it appears that the control of endocytic and phagocytic pathways, including the 
antigen export to the cytosol, might be of significant importance for this process (Alloatti et al. 
2016, Gros and Amigorena 2019). Practically, cross-presenting DC can be determined by 
their phenotype. Mouse studies showed that the XC chemokine receptor 1 (XCR1) is 
expressed on CD8+ DC which are capable of antigen cross-presentation, suggesting that 
cross-presentation is exclusively restricted to XCR1+ DC (Bachem et al. 2012). Since XCR1 
is a conserved selective marker for mammalian cell homologs of murine CD8+ DC, it is an 
appropriate lineage marker for cross-presenting DC in other species (Crozat et al. 2010).  
After antigen uptake or exposure to pathogens, DC undergo a complex transformation called 
maturation. This implies extensive morphological and functional changes. DC maturation can 
be divided into three main phases, starting with the early maturation (0 to 6 h of maturation), 




matured DC (over 20 h of maturation) (Alloatti et al. 2016). A fully mature DC has a reduced 
capacity to phagocyte and process antigens but shows an increased T cell stimulatory 
capacity, apparent by the upregulated expression of co-stimulatory molecules like CD40, 
CD80 and CD86 (De Smedt et al. 1996, Reis e Sousa 2006). Maturation also initiates the 
upregulation of the CC chemokine receptor 7 (CCR7), leading to migration to the local 
draining lymph nodes where interaction with naïve T cells occurs (Braun et al. 2011, Ritter et 
al. 2004).  
1.2.2 CMV host entry, spread and immune response 
Most CMV infections occur by transmission of body fluids and blood from acutely or 
chronically infected individuals (Keen 1985). However, to date no oral target cells have been 
identified, hence the oral entry of CMV is still unproven (Farrell et al. 2019). It has been 
suggested that CMV and other herpesviruses enter the host via olfactory epithelia (Milho et 
al. 2012, Shivkumar et al. 2013). In case of an intraperitoneal (i.p.) infection, which is a 
common experimental route, MCMV colonizes circulating monocytes, inducing a biphasic, 
monocyte-associated viraemia with primary spread to liver and spleen followed by secondary 
spread to the salivary glands where latency takes place (Collins et al. 1994). In addition, after 
olfactory infection with MCMV, infected DC were identified in draining lymph nodes, blood 
and salivary glands suggesting that viral spread was facilitated by DC being used as a 
transport vehicle (Farrell et al. 2017).  
The immune response to CMV engages both humoral and cellular immunity. During primary 
infection the complement system is activated, bridging innate and humoral immune 
responses by the induction of inflammatory mediators, opsonization of pathogens and 
degradation of infected cells (Miller-Kittrell and Sparer 2009). Furthermore, specific 
antibodies that recognize epitopes of various CMV proteins are generated by the host. In 
particular, tegument proteins, envelope glycoproteins and nonstructural proteins such as the 
immediate early 1 (IE1) protein are targets of these antibodies (Jonjić et al. 1988, La Rosa 
and Diamond 2012). The most striking feature of CMV infection is the maintenance of a great 
number of CMV-specific memory T cells, a phenomenon termed memory inflation (Karrer et 
al. 2003). The T cell response to CMV is broadly specific, targeting CMV proteins from all 
three phases of lytic infection (immediate early, early and late) as well as all types of 
structural and non-structural proteins (Elkington et al. 2003). The generation of a CD8+ T cell 
response is essential to control acute infection and reactivation. Interestingly, it is suggested 
that the priming of CD8+ T cells is dominated by antigen cross-presentation (Busche et al. 
2013). The number of memory T cells increases lifelong and constitutes approximately 10% 
of the circulating CD4+ and CD8+ memory T cell repertoires of HCMV-exposed individuals 




During early primary infection cells of the innate immune system recognize the virus. 
Activated pDC secrete IFN-/ and Interleukin-12 (IL-12), promoting the activation of DC, 
macrophages and Natural Killer (NK) cells to limit viral replication and to protect adjacent 
cells against infection (Dalod et al. 2003, Swiecki et al. 2010). NK cells are cytotoxic cells of 
the innate immune response that play an important role in detecting and eliminating infected 
cells. They are responsible for the immediate control of viral infections. In general, infections 
lead to a reduction of MHCI surface expression. Since NK cell activation is controlled by 
inhibitory receptors interacting with MHCI on the cell surface of target cells in a healthy 
individual, an infection-induced reduction of MHCI leads to an activation of NK cells and 
therefore to the lysis of the cell. This process is also called “Missing self recognition” 
(Ljunggren and Kärre 1990).  
During the acute infection phase NK cells expressing the C-type lectin receptor Ly49H+ are 
indispensable to control MCMV in vivo. Once activated, they recruit inflammatory effector 
cells by secreting specific cytokines and chemokines, inter alia IFN- and XCL1 (Dorner et al. 
2004). XCR1+ CD8+ DC are attracted to the site of infection, where they take up antigens 
and interact with NK cells to keep the balance between positive and negative effects of IFN-
/ for the optimal control of MCMV infection (Thomas and Yang 2016). NKT cells are also 
efficient regulators of early host responses. NKT cells are a specialized population of T cells 
that co-express restricted T cell receptors (TCR) and receptors of the NK lineage (Bendelac 
et al. 1997). It appears that NKT cells do not play a critical role in restricting early acute-
phase infection but may play a role in helping to activate immune responses that control viral 
replication at later stages (Van Dommelen et al. 2003). The antiviral response in MCMV 
infected submaxillary salivary glands involves both innate and acquired regulatory and 
effector cells that are sustained in higher numbers throughout the chronic phase of infection. 
Here, especially CD8+ T cells primed against IE1 dominate the immune response 
(Cavanaugh et al. 2003). Despite the strong immune response launched by the host against 
CMV, the virus cannot be eliminated. 
1.2.3 Immune evasion by CMV 
Due to million years of co-evolution, herpesviruses evolved mechanisms to modulate both 
innate and adaptive immune responses to their own benefit. For HCMV more than 40 gene 
products were recognized that play a role in modulating the host immune response including 
the complement and interferon system, the chemokine network and immune cell interaction 
(Miller-Kittrell and Sparer 2009, Mocarski et al. 2013). Since antigen presentation by MHC 
class I molecules results in a CD8 T cell response, it might be expected that CMV evolved 




activation (Rölle and Olweus 2009). Since DC are key players in T cell activation, it is not 
surprising that CMV targets these cells. In vitro, CMV can infect DC while inhibiting their 
function on several levels: maturation, migration, antigen processing and T cell activation. 
DC infected with HCMV or MCMV show a downregulation of MHCI and MHCII resulting in a 
reduced antigen-presenting capacity (Andrews et al. 2001, Raftery et al. 2001). US6, 
encoded by HCMV, impedes antigen processing by preventing the transport of peptides 
through the TAP pore (Patro 2019). In addition, CMV infection inhibits DC maturation through 
the downregulation of costimulatory molecules CD40, CD80 and CD86, and by impairment of 
cytokine production (Andrews et al. 2001, Beck Kerstin et al. 2003, Moutaftsi et al. 2002). 
Furthermore, DC migration is prevented by the downregulation of certain chemokine 
receptors like CCR7 that are responsible for homing to lymphoid organs (Moutaftsi et al. 
2004). Many of the CMV immune modulating genes are homologs of host genes that are 
involved in the immune response and which exhibit similar functions as the CMV genes. For 
example, to avoid NK-mediated clearance, CMV imitates host MHCI (Beck Stephan and 
Barrell 1988, Farrell et al. 1997). The RCMV-E C-type lectin homolog RCTL is another gene 
used to control NK cell activation. RCTL interacts directly with the NKR-P1B inhibitory 
receptor on NK cells leading to protection of the infected cell (Voigt et al. 2007).  
Although CMV has developed various strategies to interfere with the host immune system 
and paralyzes the most potent APC, virus infection is largely controlled by a healthy immune 
system. Consequently, the balance between immune response and CMV evasion allows 
survival of both the virus and the host. 
1.3 Chemokines, chemokine receptors and viral mimicry 
One immune evasive strategy evolved by herpesviruses is the exploitation of the chemokine 
system by expressing homologs of chemotactic cytokines and receptors. These viral 
homologs can cause interference of cell migration, gene expression and leukocyte 
communication (Alcami 2003, Pontejo and Murphy 2017).  
1.3.1 Classification and characterization of chemokines and chemokine receptors 
Chemokines are small secreted molecules with a molecular weight of 8 to 12 kDa. Together 
with their receptors, they direct cell migration and control inflammation, lymphoid 
development and angiogenesis (Rossi and Zlotnik 2000). Chemokines are classified into four 
groups based on the number and spacing of conserved cysteine residues located at their N-
terminus (Rollins 1997). The groups designate the date of discovery (, ,  and ) and 
describe the number and position of the cysteine residue(s) (CXC, CC, C and CX3C) (Figure 




(GPCR). The GPCR family is characterized by seven transmembrane domains. Since the 
specificity of each GPCR subtype strictly follows the associated chemokine class, they are 
named according to the structural subgroup they bind followed by an “R” for receptor and a 
number corresponding to the date of discovery (Bacon et al. 2003).  
 
Figure 4: The four chemokine classes and their respective GPCR. Chemokines are classified into four 
groups, based on the number and relative position of their N-terminal cysteine residues (C, CC, CXC, CX3C) or 
the date of discovery (, , , ). For each class, one representative chemokine is listed. C is a cysteine residue 
and X a non-cysteine amino acid. Modified after (Sodhi et al. 2004). 
Chemokines are produced as pro-peptides that are cleaved during secretion. The pro-
peptide comprises a signal peptide that guides the pro-peptide through the protein secretion 
pathway to the protein target location. The signal peptide consists of around 20-30 amino 
acids, involving a positive charged domain at the N-terminus, a hydrophobic core and an 
uncharged to negative charged region within the cleavage site (Owji et al. 2018, von Heijne 
1990). As active mature proteins, chemokines bind GPCR which activates G proteins. 
Activated G proteins stimulate, according to their receptor-coupling specificities, effector 
molecules, including phospholipases, protein kinases and GTPases, turning on signaling 
cascades within the cell (Sodhi et al. 2004). This triggers intracellular signaling pathways that 
regulate cellular migration and activate other cellular events (Mackay 2001). 
1.3.2 Viral mimicry 
Since chemokines and GPCR are the initial activators of crucial physiological processes, it 
appears plausible that viruses imitate and use them to their own advantage. This molecular 
mimicry can facilitate viral infection, replication, dissemination or immune evasion (Murphy 
2001). On the one hand, viral mimics can exhibit similar sequences and splicing patterns 
indicating divergent evolution. On the other hand, there are molecules with structures 
unrelated to chemokines or chemokine receptors but which bind to chemokines and GPCR 
to distract their function. The latter might be an example for convergent evolution. On this 
basis chemokine mimics can be divided into three subclasses: chemokine homologs, 




(Murphy 2001). Chemokines encoded by viruses can operate as agonists that activate or 
antagonists that block their target receptors.  
Four chemokine-like genes in the HCMV genome have been described so far: UL128, 
UL130, UL146 (vCXCL1) and UL147 (vCXCL2) (Pontejo and Murphy 2017). The HCMV 
open reading frame (ORF) UL128 encodes the CC chemokine homolog CCL2 that was 
shown to be necessary for monocyte infection and inhibition of migration (Straschewski et al. 
2011). Although this chemokine homolog has also been identified in RCMV-E and MCMV, 
the diverse patterns of genomic organization and low amino acid sequence identity suggest 
that they cannot be considered as orthologs (Pontejo and Murphy 2017). UL128 exhibits an 
additional function as part of a protein complex with gH, gL, UL130 and UL131A that 
mediates the cell-entry process (Ryckman et al. 2008, Vanarsdall and Johnson 2012). 
Furthermore, ORF UL146 encodes vCXCL1, an agonist that is secreted by HCMV infected 
endothelial cells and attracts neutrophils. These cells contribute to the vascular 
dissemination of HCMV (Grundy et al. 1998, Yamin et al. 2016). 
Most CMV encode two or more viral chemokines except for MCMV that encodes only one 
CC chemokine MCK-2 (Saederup et al. 1999). Like UL128, MCK-2 also forms a complex 
with gH and gL to promote infection of macrophages (Wagner et al. 2013). MCK-2 is 
translated from a spliced transcript that includes ORF m131 and m129 (MacDonald et al. 
1999). RCMV-E-encoded e131/e129 is an ortholog that exhibits the same genomic 
organization as m131/m129 with two syntenic ORF (Voigt et al. 2005). Unlike its 
counterparts, RCMV-M ORF r131/r129 encodes two separate CC chemokines, RCK-2 and 
RCK-3 (Kaptein et al. 2004).  
All viral chemokines require additional viral or host GPCR to execute their proper function. 
Four HCMV-encoded viral GPCR have been described: US27, US28, UL33 and UL78 (Chee 
et al. 1990, Vischer et al. 2014). Among them, only UL33 and UL78 are conserved across all 
CMV species (MCMV m33 (Rawlinson et al. 1996); RCMV-M r33, r78 (Vink et al. 2000); 
RCMV-E e33, e78 (Voigt et al. 2005)). Viral GPCR are present on the viral envelope, 
possibly facilitating cell interaction and viral entry (Margulies et al. 1996, Varnum et al. 2004). 
Furthermore, UL33 and UL78 were shown to form heteromers with human CCR5 and 
CXCR4, resulting in translocation followed by impaired cell migration towards CCR5 and 
CXCR4 specific chemokines (Tadagaki et al. 2012). Figure 5 depicts known CMV 






Figure 5: Chemokines and chemokine receptors encoded by different CMV species.  
1.3.3 XCL1 and XCR1 
Among the chemokine classes, the -chemokines include only one member that is conserved 
among mammalian species. According to the chemokine nomenclature, this chemokine is 
designated XCL1 but was earlier described as lymphotactin, single C motif-1 (SCM-1) or 
activation-induced T-cell-derived and chemokine-related molecule (ATAC) (Kelner et al. 
1994, Kennedy et al. 1995, Yoshida et al. 1995). During a bacterial, parasitic or viral infection 
XCL1 is expressed by innate immune cells like NK cells and NKT cells (Dorner et al. 2004, 
Hedrick et al. 1997) as well as adaptive immune cells including activated CD8+ and CD4+ T 
cells (Dorner et al. 2002).  
XCL1 elicits its function by chemoattracting XCR1-expressing cells and then activating its 
target receptor (Figure 6). XCR1 is the only receptor for XCL1 and is solely expressed on a 
CD8+ subpopulation of mouse DC, CD141+ subpopulation of human DC and equivalent DC 
subsets among all mammalian species (Bachem et al. 2010, Crozat et al. 2010, Dorner et al. 




subcapsular sinus and paracortical areas of lymph nodes (Dorner et al. 2009, McLellan et al. 
2002). XCR1+ DC are capable of cross-presentation that induces an antigen-specific 
cytotoxic immune response via CD8+ T cell activation (Bachem et al. 2010). Besides 
infection, the XCL1-XCR1 axis appears to play a crucial role in the thymic establishment of 
self-tolerance by antigen presentation to medullary thymic epithelial cells (Lei and Takahama 
2012).  
 
Figure 6: XCR1-XCL1 related immune response. In response to a bacterial, parasitic or viral infection XCL1 
NK, NKT and T cells secrete XCL1. During the early innate response activated NK cells secrete, among other 
cytokines, XCL1 which chemoattracts XCR1+ DC. In the adaptive phase, secretion of XCL1 by activated CD8+ T 
cells optimizes the dialog with antigen cross-presenting DC and facilitates differentiation of CD8+ T cells to 
cytotoxic effector cells (Kroczek and Henn 2012). 
1.3.4 The RCMV-E homolog vXCL1 (e156.5) 
In 2014 the first viral -chemokine encoded by e156.5 of RCMV-E was identified and named 
vXCL1 (Geyer et al. 2014). vXCL1 shares a strong amino acid identity with rat (64%), mouse 
(58%) and human XCL1 (46%). In addition, vXCL1 chemoattracts and binds exclusively 
XCR1-expressing cells (Bauer 2018, Geyer et al. 2014). In rats, splenic CD4- DC that 
express XCR1 are assumed to be the equivalent of mouse CD8+ and human CD141+ DC 
(Hubert et al. 2006). vXCL1 consists of 114 or 115 amino acids for RCMV-B and RCMV-E, 
respectively, with a predicted molecular weight of 13 kDa and cysteine residues at position 
30 and 67 that are conserved within rXCL1 and vXCL1. The N-terminal signal peptide is 
cleaved off for secretion of the mature chemokine which is a glycosylated protein with 96 
amino acids that can be detected in the supernatant of infected rat embryonic fibroblasts 13 
h post infection (hpi) (Geyer et al. 2014). To date, among all viruses, only RCMV-E and the 





By encoding an XCL1 homolog, MuHV-8 evolved a unique strategy to interact with XCR1 
expressing DC that are possibly capable of antigen cross-presentation. Previous work 
revealed that vXCL1 chemoattracts only the XCR1-expressing DC subset and binds solely to 
this receptor (Bauer 2018, Bauer et al. 2020, Geyer et al. 2014). Furthermore, it was shown 
that vXCL1 acts as an agonist that competes with rXCL1 for XCR1. Therefore, the aim of this 
study was to investigate the impact of vXCL1 on DC and the role of the vXCL1-XCR1 axis 
during RCMV infection. The main objectives were: 
1. Characterization of rat DC subsets 
2. Identification of DC and lymphocytes in salivary glands 
3. Transcriptome and surface protein expression analysis of DC after RCMV-E wt and 
RCMV-E vxcl1 infection 
4. Comparative analysis of recombinant rXCL1 and vXCL1 regarding a potential 
downregulation effect on XCR1 







2.1 Media, buffers and solutions 
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Virus DNA preparation and plaque assay 
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Cell isolation and flow cytometry 
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Tissue disruption for Xcr1 genotyping 
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DNA electrophoresis 







Glacial acetic acid 
EDTA                        pH 7.8 
2.2 Equipment 
Table 2: Laboratory equipment and devices. 
Equipment Company 
AxioCam ICm1 Zeiss, Jena, GER 
Bacteria incubator type 3032 GFL, Burgwedel, GER 
BioDocAnalyze Biometra, Jena, GER 
Centrifuge 5415 D Eppendorf, Hamburg, GER 
CO2 Incubator Memmert, Schwabach, GER 
CO2 incubator HERAcell 240i Thermo Scientific, Schwerte, GER 
Flow Cytometer Cytoflex Beckman Coulter, Brea, USA 
Flow cytometer Fortessa BD Pharmingen, San Diego, USA 
Flow cytometer MACSQuant Analyzer 10 Miltenyi Biotec, Bergisch Gladbach, GER 
FLUOstar Omega microplate reader BMG Labtech, Ortenberg, GER 
Freezer -20°C Liebherr, Bulle, CH 





Gentle MACS Dissociator Miltenyi Biotec, Bergisch Gladbach, GER 
GFL® Waterbath Gesellschaft für Labortechnik mbH, 
Burgwedel, GER 
Heraeus Fresco 17 centrifuge Thermo Scientific, Schwerte, GER 
Heraeus Fresco 21 centrifuge Thermo Scientific, Schwerte, GER 
Heraeus Multifuge 1S-R centrifuge Thermo Scientific, Schwerte, GER 
Hot plate magnetic stirrer IKA® RCT basic IKA-Werke GmbH & Co. KG, Staufen, GER 
Laminar Flow Safe 2020 Thermo Scientific, Schwerte, GER 
Light microscope Axiovert 25 Zeiss, Jena, GER 
Light microscope Nikon Eclipse TS100 Nikon, Düsseldorf, GER 
LightCycler® 480 Roche Life Science, Penzberg, GER 
Liquid nitrogen tank Biosafe® Cryotherm, Kirchen/Sieg, GER 
Mastercycler epgradient S Eppendorf, Hamburg, GER 
MaxQ™ 7000 Water Bath Orbital Shaker Thermo Scientific, Schwerte, GER 
Microwave 800 Severin, Sundern, GER 
MP FastPrep® -24 MP Biomedicals, Santa Ana, USA 
NanoDrop 8000 Thermo Scientific, Schwerte, GER 
Neubauer counting chamber Marienfeld, GER 
Neubauer counting chamber VWR International GmbH, Darmstadt, GER 
Pipetus® Hirschmann Laborgeräte GmbH & Co. KG, 
Eberstadt, GER 
Refrigerator  Bosch, Gerlingen, GER 
Sorvall Lynx 4000 centrifuge Thermo Scientific, Schwerte, GER 
Sorvall RC6+ centrifuge Thermo Scientific, Schwerte, GER 
Thermocycler T 3000 Biometra, Jena, GER 
Thermomixer comfort Eppendorf, Hamburg, GER 
Ultracentrifuge XL90 Beckman Coulter, USA 
UV Stratalinker™ 2400 Stratagene, Cedar Creek, USA 






Table 3: Consumable list. 
Consumables Company 
0.2 ml thin wall PCR tubes Thermo Scientific, Schwerte, GER 
1 ml, 2 ml, 5 ml, 10 ml and 50 ml syringes B. Braun Melsungen AG, Melsungen, GER 
10 cm and 15 cm cell culture dishes TPP, Trasadingen, CHE 
15 ml and 50 ml centrifuge tubes Azer Scientific Inc., Hamburg, GER 
24-well tissue culture plates TPP, Trasadingen, CHE 
30 μm MACS smart strainer Miltenyi Biotec, Bergisch Gladbach, GER 
50 μm filter CellTrics® Sysmex Europe GmbH, Norderstedt, GER 
6-well tissue culture plates Sarstedt, Nümbrecht, GER 
70 μm and 100 μm nylon cell strainer BD 
Falcon™ Corning 
BD Pharmingen, San Diego, USA 
96-well MaxiSorp microtiter plates  Nunc, Roskilde, DNK 
96-well tissue culture plates Sarstedt, Nümbrecht, GER 
96-well U-bottom plates Nunc, Roskilde, DNK 
Art tips (20 µl, 200 µl, 1000 µl) Thermo Scientific, Schwerte, GER 
Cluster tubes Corning, Salt Lake City, USA 
C-Tubes Miltenyi Biotec, Bergisch Gladbach, GER 
MACS cell separation columns (MS 
columns) 
Miltenyi Biotec, Bergisch Gladbach, GER 
Minisart® Syringe Filter (0.22 μm and 0.45 
μm) sterile filter 
Sartorius Stedim Biotech, Göttingen, GER 
Nunc™ CryoTube™ vials Thermo Fisher Scientific, Jiangsu, CHN 
PD-10 columns GE Healthcare, München, GER 
Polyallomer tubes (25x89 mm) Beckmann Coulter, Krefeld, GER 
RNase-Free Tubes Zymo Research, Irvine, USA 
Serological pipettes (5 ml, 10 ml, 25 ml) Sarstedt, Nümbrecht, GER 
Single-use pipetes (50 ml) Carl Roth, Karlsruhe, GER 
Slide-A-Lyzer Dialysis cassette Thermo Fisher Scientific, Schwerte, GER 






Table 4: Software used in this study. 
Software Manufacturer 
Adobe Illustrator CS6 Adobe Systems Inc., San José, USA 
EndNote Thomson Reuters, London, UK 
FACSDiva Software BD Pharmingen, San Diego, USA 
FlowJo Software v10.4 Tree Star Inc., Ashland, USA 
Geneious Prime Biomatters Ltd, Auckland, NZ 
GraphPad Prism 8 GraphPad Software, Inc., La Jolla, USA 
LightCycler® 480 Software Roche Life Science, Penzberg, GER 
MACSQuantify™ Software Miltenyi Biotec, Bergisch Gladbach, GER 
MARS Data Analysis Software BMG Labtech, Ortenberg, GER 
Microsoft Office Microsoft Corporation, Redmond, USA 
R R Core Team 
ZEN (blue edition) 2.3 Carl Zeiss Microscopy GmbH, Jena GER 
2.5 Chemicals 
Table 5: Chemicals. 
Chemical Supplier 
200 mM L-Glutamine PAA Laboratories, Cölbe, GER 
2x MEM Gibco, Thermo Fisher Scientific, Schwerte, 
GER 
Agarose Carl Roth, Karlsruhe, GER 
Bovine serum albumin, low endotoxin Gemini Bio-Products, West Sacramento, 
USA 
ddH2O Sigma-Aldrich, Inc., St. Louis, USA 
Dulbecco’s Modified Eagle medium Thermo Scientific, Waltham, USA 
Fetal calf serum PAN Biotech GmbH, Regensburg, GER 
GelRed Nucleic Acid Gel stain Biotium, Fremont, USA 
Ionomycin calcium salt from Streptomyces 
conglobatus 




Isoflurane Baxter GmbH, Unterschleißheim, GER 
Methylcellulose Sigma-Aldrich, Inc., St. Louis, USA 
NycoPrep® 1.077 Progen, Heidelberg, GER 
OptiPrep™ (Iodixanol) Progen, Heidelberg, GER 
Pacific Orange™ Succinimidyl Ester Thermo Fisher Scientific, Schwerte, GER 
Pancoll rat PAN Biotech, Aidenbach, GER 
Penicillin/Streptomycin (100x) PAA Laboratories, Cölbe, GER 
Phorbol 12-myristate 13-acetate Sigma-Aldrich, Inc., St. Louis, USA 
Puromycin Dihydrochlorid (Calbiochem) Merck Chemicals GmbH, Darmstadt, GER 
Roswell Park Memorial Institute medium Thermo Scientific, Waltham, USA 
TRIzol® LS Reagent Life Technologies, Carlsbad, USA 
Trypsin-EDTA 1x in PBS Biowest, Nuaillé, FR 
Trypan blue Sigma-Aldrich, Inc., St. Louis, USA 
2.6 Reagents 
Table 6: Reagents. 
Reagent Supplier 
1 kb DNA ladder Thermo Scientific, Schwerte, GER 
100 bp DNA ladder Thermo Scientific, Schwerte, GER 
6x Loading dye Thermo Scientific, Schwerte, GER 
100 mM dNTP set Thermo Scientific, Schwerte, GER 
dNTP mix, 10 mM each Thermo Scientific, Schwerte, GER 
TMB Substrate Solution Thermo Scientific, Schwerte, GER 
Lamda-DNA-TE buffer Fermentas, Massachusetts, USA 
2.7 Kits 
Table 7: Utilized kits. 
Kit Manufacturer 
BigDye Terminator v3.1 Cycle Sequencing 
Kit 




DNeasy Blood & Tissue Kits Qiagen, Hilden, GER 
NEBNext® Ultra II Directional RNA Library 
Prep Kit for Illumina® 
New England Biolabs, Massachusetts, USA 
Platinum™ Taq DNA Polymerase Invitrogen, Massachusetts, USA 
RNA Clean & Concentrator-25 kit Zymo Research, Irvine, USA 
2.8 Primers and Probes 
Primers were ordered from Invitrogen™ (Thermo Fisher Scientific) and dissolved in nuclease 
free water (Sigma-Aldrich) to 100 µM. For PCR reactions primers were diluted to 10 μM and 
stored at -20°C. TaqMan probes used in quantitative real-time PCR were purchased from 
TIB MOLBIOL, dissolved in nuclease free water to a working concentration of 10 μM and 
stored at -20°C.  
Table 8: Nucleotide sequences of used primers. 
Primer/ Probe name Sequence (5′ to 3′) 
Xcr1 genotyping 
XCR1 Intron 3204 fwd CCTCCCATTCTATAGACCATCTC 
XCR1 Exon 3659 rev AACCAGGCTGTTACCCACCAGG 
RCMV-E vxcl1 region 
SG vATAC Seq fwd TAACGTACAATGCGATCATATTC 
HG6 fwd 1284 CGACATGGGCCGTCAATGTG 
vATAC seq 186691 CACGAAACCATCTGCGTAAG 
RCMV-B vxcl1 region 
vXCL1 B rev CTTCCAGTCCCTTACAGCGG 
vXCL1 B fwd TGATATGGCGGATCCGTTCG 
Seq vXCL1 B rev TGCTTCTATATCAGCACTGTGATCT 




Quantitative real-time PCR 
RCMV gB-1008F CAAGGCCATCAGAACGGATC 






RNASeq qPCR  
NEBnext_qPCR_fwd TCC CTA CAC GAC GCT CTT CCG ATC 
NEBnext_qPCR_rev GTT CAG ACG TGT GCT CTT CCG ATC 
TaqMan probes 
gB (55-1050 TM) FAM-CACAAACGTTGCGGTCAGACTTTTCGAC-
TAMRA 
c-myc (myc-6049TM) FAM-TGCCCTGCGTGACCAGATCC-TAMRA 
2.9 Plasmids 
Table 9: List of plasmids used and generated in this study. 
Plasmid Name Description Reference 
pTopo2.1-gB gB standard curve for 
quantitative real-time PCR 
Ettinger, 2012 
pTopo2.1-c-myc c-myc standard curve for 
quantitative real-time PCR 
Ettinger, 2012 




Generation of RCMV-B vXCL1 
deletion mutant  
Kindly provided by Robert 
Jan Lebbink, UMC 
Utrecht 
2.10 Antibodies and beads 
Fluorophore-coupled antibodies were titrated and stored at 4°C. Dig-coupled antibodies were 
stored at -80°C.   
Table 10: Antibodies used in this study. 
Specifity Clone Label Source 
Anti-mouse IgG  A647 Life Technologies, Carlsbad, USA 
Anti-mouse IgG  HRP Dako, Hamburg, GER 
CD103 Ox-62 A647 BioLegend, London, UK 
CD103 Ox-62 BV428 BD Pharmingen, San Diego, USA 




CD161a NKR-P1A PE BD Pharmingen, San Diego, USA 
CD161a REA227 PE-Vio770 Miltenyi Biotec, Bergisch Gladbach, GER 
CD172a 
(SIRP) 
Ox-41 PE BioLegend, London, UK 
CD3 REA223 APC-Vio770 Miltenyi Biotec, Bergisch Gladbach, GER 
CD3 REA223 VioBlue Miltenyi Biotec, Bergisch Gladbach, GER 
CD4 W3/25 PE-Cy7 BioLegend, London, UK 
CD45RA Ox-33 PerCP-Cy5.5 BioLegend, London, UK 
CD45RA Ox-33 PE BD Pharmingen, San Diego, USA 
CD45RA Ox-33 APC-Cy7 BD Pharmingen, San Diego, USA 
CD8a REA437 FITC Miltenyi Biotec, Bergisch Gladbach, GER 
Isotype Mouse 
IgG2b, κ 
MPC-11 PE BioLegend, London, UK 
MHCII REA510 PerCP-Vio700 Miltenyi Biotec, Bergisch Gladbach, GER 
MHCII (RT1B) Ox-6 FITC BD Pharmingen, San Diego, USA 





A645 IBA GmbH, Göttingen, GER 
Streptavidin  APC BioLegend, London, UK 
vXCL1 RCMV-11  S. Jonjic, University of Rijeka, Rijeka, HR 
XCR1 ZET PE BioLegend, London, UK 
2.11 Viruses 
All viruses were titrated by plaque assay and stored at -80°C.  
Table 11: RCMV-E and RCMV-B recombinant viruses. 
Virus Description Source 
RCMV-E wild type RCMV isolated from Rattus norvegicus 
propagated on rat embryonic fibroblasts 
(REF). 
William H. Burns, 
Baltimore, USA (Voigt et 
al. 2005) 
RCMV-E vxcl1 The vxcl1 ORF was replaced by a mCherry-
cassette followed by removing the 
fluorescent marker by Cre recombinase. 
Generated by Anna 




RCMV-E gfp A green fluorescent protein (gfp)-cassette 
was introduced adjacent to e32. 
Generated by Aila 
Daugs (Voigt laboratory) 
RCMV-B wild type RCMV isolated from salivary glands of a rat 
(Rattus norvegicus) captured in Berlin and 
plaque purified (SG1 D12) on REF. 
Isolated by Sebastian 
Voigt, plaque purified by 
Henriette Geyer (Geyer 
et al. 2015) 
RCMV-B vxcl1 REF were transfected with RP-557 EFS 
puro-T2A-Cas9 containing three different 
guide RNAs (RC-2425, RC-2424, RC-2423) 
targeting RCMV-B vxcl1 and then infected 
with RCMV-B wt. Mutants were screened 
and plaque purified (RCMV-B vxcl1 H3) 
Generated by Julia 
Madela-Mönchinger with 
technical assistance of 
Yue Yu (part of this 
dissertation 4.5) 
2.12 Eukaryotic cells 
To propagate virus and conduct infection experiments, REF were obtained from William H. 
Burns (Baltimore, USA). 
2.13 Rat strains 
8 to 9-week-old male inbred Lewis rats were purchased from Charles River. Xcr1 knockout 
rats were generated from the Sprague Dawley-Hannover outbred strain by Elena Popova 
and Michael Bader in the Max Delbrück Center for Molecular Medicine (MDC). Xcr1 knockout 
rats were characterized by Agnieszka Bauer (Bauer 2018). All rats were kept and bred in the 







3.1 Molecular biology 
3.1.1 Polymerase Chain Reaction (PCR) 
In order to amplify DNA fragments, PCR was performed using Taq DNA Polymerase kit 
(Invitrogen) with 1x PCR reaction buffer, 1.5 mM MgCl2, 0.2 mM of dNTP mix, 0.2 µM of each 
primer and 2 Units (U) of Platinum Taq DNA polymerase. Amplification was performed in a 
thermal cycler (Mastercycler epgradient S, Eppendorf) with thermal cycling conditions shown 
in Table 12. Annealing temperatures were calculated in Geneious according to the primer 
melting temperature. PCR-products were loaded on a 0.8-2% agarose gel supplemented 
with 1x GelRed nucleic stain to allow an analysis under ultraviolet (UV) light by using a gel 
documentation station (BioDocAnalyze, Biometra).  
Table 12: Standard cycling conditions for PCR. 
Step Temperature Time Cycles 
Initial denaturation 94°C 2 min 1 
Denaturation 94°C 30 sec  
Annealing 50-60°C 30 sec 35-40 
Elongation 72°C 60 sec/kb  
Final elongation 72°C 1-5 min 1 
Hold 4°C ∞ 1 
3.1.2 Genotyping of Xcr1 knockout rats 
To genotype rats, ear biopsies were incubated in 100 µl Ear buffer containing 1 mg/ml 
proteinase K at 55°C until the tissue was completely digested. Proteinase K was heat 
inactivated at 95°C for 5 min followed by mixing the sample with TE/RNase buffer. Table 13 
shows the PCR set up. The PCR reactions were conducted with Taq DNA Polymerase kit 
(Invitrogen) with 1.8 mM MgCl2 and 3 U Platinum Taq Polymerase. PCR-products were 
loaded on a 1.5% agarose gel containing 1x GelRed nucleic stain and analyzed under UV 





Table 13: PCR cycling conditions for Xcr1 genotyping. 
Step Temperature Time Cycles 
Initial denaturation 94°C 3 min 1 
Denaturation 94°C 20 sec  
Annealing 58°C 30 sec 35 
Elongation 72°C 40 sec/kb  
Final elongation 72°C 5 min 1 
Hold 4°C ∞ 1 
3.1.3 Quantitative real-time PCR (qRT-PCR) 
In order to detect and quantify glycoprotein B (gB) in different rat tissues, a quantitative PCR 
was performed using Taq DNA Polymerase kit (Invitrogen) with 1x buffer, 4 mM MgCl2, 0.4 
mM dNTP Mix, 300 nM of each primer, 100 nM of probe and 1 U of Platinum Taq DNA 
polymerase. qRT-PCRs were conducted in the LightCycler® 480 (Roche) with cycling 
conditions listed in Table 14. To quantify copy numbers, a standard curve with a defined 
number of copies of plasmids containing the target gene were used. The detected copy 
number of gB was normalized to the housekeeping gene c-myc. 
Table 14: Quantitative real-time PCR. 
Step Temperature Time Cycles 
Initial denaturation 95°C 5 min 1 
Denaturation 95°C 15 sec 
45 
Amplification 60°C 30 sec 
3.1.4 DNA isolation from tissue 
Frozen organs were thawed and equilibrated to RT and transferred to a tube with 
Teflonbeads. After 180 µl Buffer ATL (Qiagen DNeasy Blood and Tissue Kit) was added, 
organs got homogenized with TissueLyzer Fastprep (MP) with 6.5 m/s 45 s two times. Then, 
homogenates were centrifuged for 2 min at 10000*g and incubated with 2 mg/ml proteinase 
K (provided in Qiagen Kit) for at least 3 h at 56°C in a ThermoMixer. After incubation 1 mg/ml 
RNase A was added and incubated for 5 min at RT. DNA extraction was performed 
according to the instructions of Qiagen DNeasy Blood and Tissue Kit. DNA concentration 




3.1.5 Isolation of virion DNA 
RCMV virion DNA was isolated from REF infected with a low multiplicity of infection (MOI) of 
0.05-0.1. When the cytopathic effect (CPE) reached 100%, plates were frozen at -80°C. 
Following thawing at 37°C cell debris were removed by centrifugation at 9200*g for 10 min at 
RT and virus was pelleted at 27000*g for 3 h at 4°C. To remove cellular DNA, the virus pellet 
was incubated with 0.2% (v/v) FCS and 1 µg/ml of both, RNase and DNase I for 15 min at 
37°C. After centrifugation at 30600*g for 90 min at RT, the virus capsid was destabilized with 
2.7 ml TE9 buffer containing 0.24 mg/ml proteinase K in 10% (w/v) SDS at 37°C while 
shaking at 200 rpm overnight. The next day, viral DNA was mixed with a phenol/ chloroform/ 
isoamylalcohol mixture (Roti-phenol) and transferred to a Phase Lock Gel heavy 15 ml falcon 
followed by centrifugation at 4000 rpm for 10 min. The viral DNA containing upper aqueous 
phase was mixed with 1/10 volume of 3 M sodium acetate and 2.5 volumes of ice-cold 96% 
(v/v) ethanol and centrifuged at 13000*g for 30 min at 4°C. The pellet was dried overnight at 
RT and reconstituted in 150 μl H2O. DNA concentration was determined by using a 
NanoDrop 8000 spectrophotometer.  
3.1.6 DNA Sequencing 
In order to determine vxcl1 deletion mutants, supernatants of single plaques were incubated 
at 95°C for 5 min. To enrich the area of interest a first PCR was performed as described in 
Table 12. 5 µl of the amplified DNA was then purified with 2 µl ExoSAP-IT™ PCR Product 
Cleanup Reagent (Applied Biosystems™) with settings listed in Table 15. For the sequencing 
PCR BigDye Terminator v3.1 cycle sequencing kit was used with 1x buffer, 0.5 µM of each 
primer and 1x BigDye Premix in 10 µl H2O with reaction conditions shown in Table 16. 
Products were sequenced by the Sanger method which was accomplished by the 
sequencing facility MF2 at the Robert Koch Institute. Digital raw data were evaluated by 
using Geneious.  
Table 15: PCR clean-up protocol. 
Step Temperature Time 
Degradation of primers and nucleotides 37°C 4 min 
Inactivation of ExoSAP-IT™ reagent 80°C 1 min 






Table 16: Standard cycling conditions for sequencing reactions. 
Temperature Time Cycles 
96°C 1 min 1 
96°C 10 sec  
50°C 5 sec 25 
60°C 4 min  
4°C ∞ 1 
3.1.7 RNA isolation and sequencing 
Cultured and infected DC were lysed with 3x volume of Trizol LS (Thermo Fisher Scientific). 
After adding 0.2 ml Chloroform per 1 ml sample and subsequent centrifugation at 13000*g 15 
min at 4°C, RNA was collected from the aqueous phase. Further RNA purification was 
performed with the RNA Clean & Concentrator 25 kit (Zymo Research) following the 
manufacturer’s protocol. The total RNA concentration was quantified by Qubit Fluorometer 
(Invitrogen) and sample quality was verified by an Bioanalyzer (Agilent DNA 1000 Chip). For 
RNA sequencing from Ox-62 enriched DC, the NEBNext® Ultra II Directional RNA Library 
Prep Kit for Illumina® was used with 60% of suggested volumes by the manufacturer's 
protocol. About 600 ng total RNA were used for mRNA isolation with magnetic Oligo dT 
Beads d(T)25 which bind to the poly-A tail of mRNA. After washing beads with RNA Binding 
buffer (2x), beads were incubated with RNA in a thermal cycler at 65°C for 5 minutes 
followed by cool down to 4°C with the heated lid set at ≥ 75°C to denature the RNA and 
facilitate binding of the mRNA to the beads. Samples were incubated another 5 minutes at 
RT to allow the mRNA to bind to the beads. To remove unbound RNA, tubes were placed on 
a magnetic rack until the solution cleared. Then the supernatant was discarded and samples 
washed with 120 µl Wash buffer. To elute the mRNA from the beads, the pellet was 
resuspended in Tris buffer and incubated in a thermal cycler with 80°C for 2 minutes, then 
held at 25°C with the heated lid set at ≥ 90°C. After further bead-binding as described above, 
the mRNA was fragmented with First Strand Synthesis Reaction buffer and Random Primer 
Mix (2x) in a thermal cycler with the heated lid set at 105°C as follows in Table 17: 
Table 17: Elution and Fragmentation of mRNA. 
Temperature Time 
94°C 15 min 
4°C ∞ 
Samples were put on a magnetic rack and supernatant containing fragmented mRNA was 




NEBNext First Strand Synthesis Enzyme Mix were added to the fragmented RNA and 
incubated in a preheated thermal cycler with the heated lid set at ≥ 80°C as follows in Table 
18: 
Table 18: First Strand cDNA synthesis program. 
Temperature Time 
25°C 10 min 
42°C 15 min 
70°C 15 min 
4°C ∞ 
Immediately, Second Strand cDNA synthesis was performed with NEBNext Second Strand 
Synthesis Reaction Buffer with dUTP Mix (10x) and NEBNext Second Strand Synthesis 
Enzyme Mix in a thermal cycler for 1 h at 16°C with the heated lid set at ≤ 40°C. Double-
stranded cDNA was then purified with SPRIselect Beads by incubation at RT for 5 min. 
Supernatant was removed On a magnetic rack and samples were washed with 80% ethanol 
twice. To repair DNA ends from sticky to blunt ends with dA-tails to prevent ligation (End 
Prep reaction), DNA was eluted from beads with 0.1x TE buffer (provided) and incubated 
with NEBNext Ultra II End Prep Reaction Buffer and NEBNext Ultra II End Prep Enzyme Mix 
in a thermal cycler with the heated lid set at ≥ 75°C as follows in Table 19: 
Table 19: End Prep reaction program. 
Temperature Time 
20°C 30 min 
65°C 30 min 
4°C ∞ 
To label the samples with individual Index numbers, adaptors were ligated with 5-fold dilution 
(because of 600 ng input RNA) in ice-cold Adaptor Dilution Buffer, NEBNext Ligation 
Enhancer and NEBNext Ultra II Ligation Master Mix. After incubation for 15 minutes at 20°C 
in a thermal cycler, USER Enzyme was added to the ligation mixture and incubated for 
another 15 minutes at 37°C with the heated lid set to ≥ 45°C. After this, purification of the 
Ligation Reaction was performed with SPRIselect Beads as described above. After eluting 
adaptor ligated DNA with 0.1x TE buffer, 1 µl was used for SYBRgreen qPCR to determine 
the number of PCR cycles enrichment. Enrichment PCR was conducted with NEBNext Ultra 
II Q5 Master Mix, Universal PCR Primer/i5 Primer and Index (X) Primer/i7 Primer in a thermal 




Table 20: PCR enrichment of Adaptor Ligated DNA. 
Step Temperature Time Cycles 
Initial Denaturation 98°C 30 sec 1 
Denaturation  98°C 10 sec 
11 
Annealing/Extension 65°C 75 sec 
Final Extension 65°C 5 min 1 
Hold 4°C ∞  
A further purification of the PCR Reaction was performed with SPRIselect Beads as 
described above and library quality was assessed on a Bioanalyzer (Agilent DNA 1000 
Chip). Pooled sequencing libraries were sequenced on an Illumina HiSeq 4000 device. After 
trimming the adapter sequence AGATCGGAAGAGCACACGT, about 18-30 million mappable 
reads per sample were obtained. 
3.1.8 Detection of differentially expressed genes 
RNA-Seq data were evaluated using the Snakemake-based tool SCORE (Wolf et al. 2020). 
SCORE uses a selection of tools for quantifying the expression of all transcripts within each 
given sample. Raw reads were initially trimmed, mapped to the current Rattus norvegicus 
reference genome (Rnor_6, https://www.ncbi.nlm.nih.gov/assembly/GCF_000001895.5) and 
quantified. Next, individual transcripts were analyzed for differential expression ( < 0.01). 
SCORE identifies significantly differentially expressed genes (DEG) that were implemented 
to associated pathways of the Kyoto Encyclopedia of Genes and Genomes (KEGG) as well 
as gene ontologies (GO). Results were visualized in heatmaps by using R. 
3.2 Protein biochemistry and flow cytometry 
3.2.1 ELISA for vXCL1 detection 
96-well flat-bottom MaxiSorp plates (Nunc) were coated with 100 μl of viral supernatant 
diluted in ELISA coating buffer and incubated overnight at 4°C. Unbound proteins were 
washed down 5 times with PBS. In order to cover free binding sites 200 μl of ELISA blocking 
buffer was added for 2 h, at RT and wells were washed twice with PBS. For vXCL1 detection 
100 μl of RCMV-11 (final conc. 0.2 µg/ml, diluted in ELISA blocking buffer) was added and 
incubated at RT for 1 h. After washing five times with ELISA washing buffer, 100 µl of 
polyclonal anti-mouse immunoglobulin-horseradish peroxidase (HRP) (final conc. 0.2 µg/ml, 
diluted in ELISA blocking buffer) was added and incubated at RT for 1 h. Following further 
five washing steps with ELISA washing buffer plates were incubated with 50 μl of 3,3',5,5'-




The reaction was stopped by adding 50 μl of 1 M H2SO4 and absorbance was determined at 
OD 450 nm by using the FLUOstar Omega microplate reader. 
3.2.2 Antibody coupling 
A monoclonal antibody against RCMV-E IE1 was generated by Vanda Juranic Lisnic in the 
laboratory of Stipan Jonjic (University of Rijeka). To couple this mAb with the fluorophore 
A647, NaN3 was removed by dialyzing 0.5 mg of 1 mg/ml concentrated antibody with the 
Slide-A-Lyzer Dialysis Cassettes with 10,000 MWCO (Thermo Fisher Scientific). After 
recovering from the dialysis cassette, the antibody was incubated for with 0.1 M NaHCO3 and 
0.1 mM A647 (Molar ratio = 15) for 1 h, at RT with gentle shaking every 10 min. The 
conjugated antibody was applied to a PD MiniTrap G-25 (GE Healthcare) column in order to 
remove unbound dye. The fluorophore-coupled antibody was eluted with PBS, protein 
concentration was measured by a NanoDrop spectrophotometer at 280 nm and 0.2% (w/v) 
BSA and 0.1% (w/v) NaN3 were added. 
3.2.3 Antigen staining with fluorophore-coupled antibodies 
In order to measure cells by flow cytometry up to 107 cells were pelleted in a 96-well U-
bottom microtiter plate at 400*g for 5 min at 4°C. To prevent unspecific binding by the 
antibody’s Fc chain cells were incubated with 45.2 µg/ml of rat gamma globulin for 5 min on 
ice. Cells were stained with fluorophore-coupled antibodies in a total volume of 50 μl for 20 to 
30 min on ice followed by two washing steps with FACS-PBS. Before measurement, 0.3 μM 
4′,6-diamidino-2-phenylindole (DAPI) or 1 µg/ml propidium iodide (PI) were added as dead 
cell markers.  
3.2.4 Fixable dead staining and intracellular staining 
To exclude dead cells from flow cytometry analysis of fixed samples antibody-stained cells 
were washed with PBS and resuspended in 200 μl of 1.34 µM Pacific Orange (PacO) diluted 
in PBS. After 25 min incubation on ice, cells were washed with PBS followed by fixation with 
2% (w/v) paraformaldehyde (PFA) for 20 min at RT in the dark. After fixation, cells were 
washed with PBS and FACS-PBS. For intracellular staining, cells were permeabilized with 
FACS-PBS containing 0.5% (w/v) saponin. Permeabilized cells were incubated 5 min on ice 
with rat gamma globulin followed by staining with either an unlabeled or fluorophore-coupled 
primary antibody. After 20 min incubation on ice in the dark, unbound antibodies were 
removed by washing once with Permeabilization buffer. In case of incubation with unlabeled 
primary antibody, incubation with the respective fluorophore-conjugated secondary antibody 
was performed for 15 min at RT. Prior to flow cytometric analysis cells were washed twice 




3.2.5 Chemokine binding 
To investigate the impact of XCL1 on XCR1-expressing DC, Ox-62-enriched spleen cells 
were incubated with different concentrations of the respective recombinant chemokines 
diluted in Chemotaxis medium for 4 h at 37°C. After incubation, cells were washed with 
FACS-PBS and stained with fluorophore-conjugated antibodies as described in section 3.2.3 
followed by flow cytometry analysis.  
3.2.6 Flow cytometry analysis 
In order to identify DC, cells were labeled with fluorophore-coupled antibodies against CD3, 
CD45RA, MHCII, CD103, XCR1 and CD4. Cells were examined in FSC and SSC to gate the 
leukocyte population. Gating in FSC-Height (FSC-H) and FSC-Area (FSC-A) was needed to 
exclude cell doublets. To discriminate dead from viable cells, DAPI or PI was added before 
measurement. Then, T cells (CD3) and B cells (CD45RA) were excluded. MHCII is a marker 
for APC whereas CD103 is expressed exclusively on DC. These two markers allowed for the 
identification of DC. DC were further gated on XCR1, CD4, CD8, CD11b/c, CD86, CD172a 
and CD54. To separate the two major DC subsets, cells were gated either on CD4 and 
XCR1 or CD4 and MHCII and referred to as CD4- and CD4+ DC.  
3.3 Virology 
3.3.1 Virus infection 
REF or DC were infected with RCMV-E or RCMV-B or recombinant viruses to generate virus 
stocks or to perform analytical experiments. REF were infected at a confluency of 70-80% in 
complete DMEM containing 2% FCS at a specific MOI. 1 h post infection virus containing 
supernatant was exchanged with complete DMEM containing 5% FCS. For ex vivo infection 
of DC, spleen cells were enriched with Ox-62 microbeads and infected with the respective 
virus in Chemotaxis medium at MOI 3 or 10.  
3.3.2 Generation of high titer virus stocks 
Several 15 cm dishes of REF were grown to a confluency of 70-80% and infected at a low 
MOI of 0.05 to 0.1 with DMEM containing 2% (v/v) FCS. After 5 to 6 days, when CPE was 
clearly visible, supernatants were collected and cell debris removed by centrifugation at 
6000*g for 20 min at 4°C. The cell pellet was resuspended in 5 ml of supernatant and 
homogenized using a pre-cooled glass douncer followed by another centrifugation at 
17000*g for 20 min at 4°C. To pellet the virus, supernatants were pooled and centrifuged at 




was homogenized with a pre-cooled glass douncer. To prepare the virus for animal 
experiments, the homogenized pellet was applied to a 15% (w/v) VSB sucrose cushion and 
virus was pelleted at 20000 rpm for 5 h at 4°C (SW32Ti rotor, Optima XL-90, Beckman 
Coulter). The virus pellet was dissolved in PBS and stored at -80°C. Viral titers were 
determined by plaque assay as described in 3.3.3. 
3.3.3 Virus titration by plaque assay 
To determine the titer of the generated virus stocks REF, grown to 70-80% confluency in 24-
well plates, were infected with 200 µl of serial dilutions of a previously generated virus stock. 
After incubation at 37°C for 1 h, the infection process was stopped by adding 1 ml Plaque 
overlay medium followed by incubation for 7 days at 37°C and 5% CO2. To stop viral 
replication, cells were fixed with 1% (v/v) PFA for 15 min at 37°C. Fixed cells were then 
stained with 1 ml Methylene blue staining solution for 30 min at 37°C. Plaque forming units 
(pfu) were counted and the viral titer was calculated by the mean value of eight replicates in 
pfu per ml. 
3.3.4 Generation of RCMV-B vxcl1 virus 
A RCMV-E vxcl1 with a Cre-Lox recombination cassette that had previously been 
generated was used to study the function of vXCL1 upon ex vivo infection. To create a 
RCMV-B vxcl1 deletion mutant, CRISPR/Cas9 technology was employed. REF were grown 
to a confluency of 70-80% and transfected with 2 µg of three different vectors using 
PolyFect® Transfection Reagent (Qiagen). Vectors were kindly provided by Robert Jan 
Lebbink (UMC Utrecht), which encoded Cas9 and the guide RNA (gRNA) recognizing vxcl1 
of RCMV-B, as well as a puromycin and ampicillin resistance cassette. To successfully select 
transfected cells, 2.5 µg/ml puromycin was added to the cultivation medium after 30 h 
incubation at 37°C, followed by another 24 h incubation. Cells were then infected with 
RCMV-B at an MOI of 0.5 for 2 h in DMEM containing puromycin. After five days a CPE was 
visible and viral supernatant was serially diluted in 96-well plates for single plaque 
purification. Plates were screened under the light microscope to detect wells with a single 
plaque. Separate supernatants of single plaques were collected and incubated at 95°C for 5 
min. Then, products of a first PCR were purified by using ExoSAP purification kit followed by 
the sequencing PCR (see section 3.1.6). After digital raw data were evaluated by using 
Geneious, promising mutants were grown and another limiting dilution was performed. Single 




3.4 Cell biology 
3.4.1 Propagating and counting cells 
REF were cultivated in complete DMEM at 37°C and 5% CO2 and propagated with sterile 
media and buffers in a laminar airflow cabinet. Dead cells were discriminated by trypan blue 
staining and cell number of REF was determined with a Neubauer counting chamber. Organ 
derived cells were counted with MACSQuant 10 after DAPI staining. 
3.4.2 Freezing and thawing cells 
Freezing of REF was carried out by centrifugation at 1200 rpm for 5 min and resuspension in 
90% (v/v) FCS and 10% (v/v) DMSO. Primary rat leukocytes were cooled down in RPMI on 
ice for 20 min followed by gentle resuspension in 1 volume FCS containing 20% (v/v) DMSO. 
REF were thawed in a water bath and washed with 8 ml complete DMEM. After 5 min 
centrifugation at 1200 rpm, cell pellets were resuspended in complete DMEM and cells were 
seeded. Rat leukocytes were thawed in a 37°C water bath. To dilute the DMSO complete 
RPMI medium was added dropwise to the cells. After centrifugation at 380*g for 8 min at 
4°C, cells were resuspended in complete RPMI, FACS- or MACS-PBS, respectively.  
3.4.3 Preparation of single cell suspensions from spleens 
Rat spleens were isolated and cut into smaller pieces. For single cell suspensions, spleens 
were homogenized using a gentleMACS dissociator (Miltenyi Biotec), program 
m_spleen_4.1. To get higher yields of DC, homogenates were digested with 500 µg/ml 
Collagenase D, 20 µg/ml DNaseI and 2% (v/v) FCS in RPMI 1640 for 25 min in a 37°C water 
bath shaking at 200 rpm. Digestion was halted by adding 10 mM EDTA for another 5 min 
under the same conditions. The cell suspension was filtered through a 100 µm nylon sieve 
(BD), centrifuged at 380*g for 8 min at 4°C, applied to NycoPrep® (PROGEN) or OptiPrep™ 
(PROGEN) density gradient centrifugation (density: 1.073 g/ml) at 1700*g for 10 min at 4°C 
without deceleration. Leukocytes were collected from the middle phase and washed twice 
with MACS-PBS. 
3.4.4 Magnetically isolation of rat DC 
In order to isolate CD103+ cells from rat spleens, NycoPrep®/ Optiprep™ enriched spleen 
cells were incubated with Microbeads (Miltenyi Biotec) bearing antibody clones of Ox-62 
according to the manufacturer’s instructions. To prevent unspecific binding on Fc receptors 
cells were incubated with 45.2 µg/ml rat gamma globulin for 5 min on ice. Cells were applied 




3.4.5 Isolation of leukocytes from salivary glands 
After rats were sacrificed by an isoflurane overdose, mandibular, parotid and sublingual 
glands (in this work referred to as salivary glands) were dissected and stored in PBS. 
Adjacent lymph nodes were removed and salivary glands were homogenized using a 
gentleMACS dissociator (Miltenyi Biotec), program m_heart_01_01. To obtain single cell 
suspensions, the homogenized tissues were digested in RPMI containing 1 mg/ml 
Collagenase D, 0.1 mg/ml DNaseI and 10% (v/v) FCS at 37°C for 1 h while shaking. 5 mM 
CaCl2 was added to enhance Collagenase D activity. Digestion was stopped by adding 10 
mM EDTA for another 5 min under the same conditions. The suspension was filtered through 
a 70 µm and 30 µm nylon sieve and washed with MACS-PBS twice. After centrifugation at 
380*g for 8 min at 4°C cells were applied to NycoPrep® density gradient centrifugation 
(density: 1.073 g/ml) at 1700*g for 10 min at 4°C without deceleration. Enriched leukocytes 
were collected from the middle phase, washed twice with MACS-PBS and resuspended in 
FACS-PBS. Cells were stained with several fluorophore-coupled antibodies as described in 
3.2.3.  
3.4.6 Preparation of single cell suspensions from lymph nodes 
Salivary gland-embedded lymph nodes were isolated and fat was removed. To gain a single 
cell suspension, lymph nodes were dissected with micro-forceps in complete RPMI followed 
by a digestion with 2 mg/ml Collagenase D and 20 µg/ml DNaseI as described in section 
3.4.3. After digestion cells were filtrated first through a 70 µm then 50 µm nylon sieve. Cells 
were stained with several fluorophore-coupled antibodies as described in section 3.2.3.  
3.4.7 Collection of blood for cell enrichment  
Blood was collected by cardiac puncture with a syringe filled with 5000 U/ml Heparin. For cell 
enrichment blood was applied to a Pancoll (PAN) gradient and centrifuged for 40 min at 
800*g without deceleration at RT. The interphase containing leukocytes was recovered and 
washed with PBS. If necessary, an erythrocyte lysis with ACK-buffer was performed. Cells 
were stained with several fluorophore-coupled antibodies as described in section 3.2.3.  
3.4.8 Chemotaxis assay 
The influence of RCMV infection and recombinant chemokines on DC migration was 
examined by a 24-well 6.5 mm transwell system with a 5 µm pore size. 500 µl of recombinant 
rXCL1 were added into the bottom chamber of the transwell plate. As a control, Chemotaxis 
medium without chemokine was added to the well. 2 *105 to 5*105 of previously stained Ox-




the upper chamber of the transwell system. After incubation for 2.5 h at 37°C and 5% CO2, 
cells that migrated into the lower chamber were analyzed by flow cytometry. Each sample 
was measured for 5 min at constant flow rate on a Fortessa flow cytometer or exactly 300 µl 
of each sample on MACSQuant 10 to count absolute numbers of migrated cells and input 
cells. The proportion of migrated cells was calculated as follows: number of migrated 
cells/number of input cells*100. 
3.4.9 Stimulation of spleen cells with PMA and ionomycin 
In order to investigate which cell subsets are expressing endogenous XCL1, spleens were 
minced and filtered through a 100 µm sieve followed by an erythrocyte lysis with ACK-buffer. 
20*106 cells were stimulated with 20 ng/ml Phorbol-12-myristat-13-acetat (PMA) and 1 µg/ml 
ionomycin in 10 ml for total of 5 h in the presence of brefeldin A for the last 3 h. Intracellular 
staining of rXCL1 was performed as described in section 3.2.4 with a commercially available 
polyclonal anti-rXCL1 antibody that was previously coupled to biotin. Detection was 
performed by using a streptavidin-APC conjugate followed by flow cytometry analysis.  
3.5 Animal experiments 
All animal experiments were performed in the RKI animal facility. Laboratory animal care and 
all experiments were carried out according to the German animal protection law (TierSchG) 
and the internationally recognized 3R principle (Refinement, Reduction, Replacement). Care 
and breeding of the rats were done by qualified animal keepers. Rats were kept in a 12 hours 
day/ night rhythm.  
3.5.1 Animal infection and sample collection 
To examine the role of XCR1 during RCMV-B infection 48 Xcr1+/+ and 48 Xcr1-/- Sprague 
Dawley rats were i.p. infected with RCMV-B or PBS and analyzed at 3, 5, 16 and 90 dpi. 
Each test group contained 6 rats. For infection RCMV-B SG1 D12 passage 3 with 1*106 pfu 
in 500 µl was used. In order to investigate the role of vXCL1, six 10-week-old Lewis rats were 
i.p. infected with RCMV-B wt SG1 D12 passage 3 or RCMV-B vxcl1 H3 passage 5, 
respectively, with 1*106 pfu in 500 µl. Uninfected rats served as a negative control (Mock). All 
RCMV-B-infected and PBS-injected animals were monitored by qualified animal keepers. 
On the respective days after infection rats were sacrificed with a lethal dose of Isofluran. 
Death was determined by monitoring the heartbeat. First, blood was collected as described 
in section 3.4.7. Then, lymph nodes, salivary glands, lung, liver and spleen were removed. 




3.5.2 Organ homogenization and titration 
Salivary glands were homogenized in 1 ml DMEM 2% (v/v) FCS with a syringe plunger and a 
70 µm Nylon sieve (BD). To dissociate cells the homogenates were manually processed 
through a precooled 5 ml glass douncer. Dilutions from 10-1 to 10-5 were titrated on REF (see 
section 3.3.3).  
3.6 Statistics 
For normally distributed data the parametric one-way analysis of variance (one-way ANOVA) 
was performed to compare the means of two or more samples. To measure the amount of 
variation between replicates a standard deviation (SD) or standard error of the mean (SEM) 
were calculated. For multiple comparisons between groups within one experiment post hoc 
tests were carried out. Whereas the Tukey’s multiple comparison test was chosen to 
compare every mean with every other mean, the Dunnett’s multiple comparison test was 
performed to compare every mean to a control mean. All statistics were calculated with 
GraphPad Prism 8 and were interpreted exploratory. Results with a high variance were 






4.1 Analysis of XCR1 expression on DC and XCL1 expression on 
lymphocytes 
4.1.1 Two major DC subsets are identified in rat spleens 
To examine DC subsets, an enrichment protocol of these cells was established. First, 
spleens were digested (Digest) followed by a density gradient centrifugation (OptiPrep) that 
led to the exclusion of erythrocytes and smaller cell debris. Finally, DC were isolated with 
magnetically labeled beads (Ox-62) (Figure 7 A). Due to enrichment, the relative number of 
DC within the living cell population increased from 1% in the digest fraction to 7.6% in 
OptiPrep and 67.4% in Ox-62 enriched fraction (Figure 7 B). The enrichment had no 
influence on cell viability which remained at 88-92% (Figure 7 C). The analysis of surface 
protein expression revealed that spleen derived rat DC lack the expression of T and B cell 
lineage markers CD3 and CD45RA, respectively. After gating on CD4 and XCR1, two major 
DC subsets could be identified. After density centrifugation the frequency of CD4- XCR1+ DC 
within the CD103+ population was 30%, whereas CD4+ XCR1- DC frequency was at 55%. 
After Ox-62 microbeads enrichment, the relative distribution of CD4- DC and CD4+ DC 
changed to 54% and 37%, respectively. 
Following the examination of further DC markers two distinct DC phenotypes could be 
identified: MHCII+ CD103+ CD4- XCR1+ CD11b/c+ CD172a(+) CD54+ and MHCII+ CD103+ 
CD4+ XCR1- CD11b/c+ CD172a+ CD54+ DC (Figure 8). The two DC subsets shared 
expression of CD11b/c and CD54. While CD4+ DC showed a high expression of the signal 
regulatory protein alpha (SIRP/ CD172a), CD4- DC exhibited low expression. In contrast to 
murine DC, rat DC did not express CD8. Apart from the two major DC subsets two other 
dim populations were visible, expressing higher amounts of MHCII (CD4+ MHCII++ and CD4- 
MHCII++). The CD4- MHC++ population expressed lower XCR1 amounts. In addition, both 






Figure 7: Isolation of DC from rat spleen. Spleens were mashed, digested and single cell suspensions were 
separated on a high density gradient (OptiPrep). DC were isolated with Ox-62 magnetically labeled beads and 
finally stained with fluorophore-conjugated antibodies targeting CD3, CD45RA, CD103, MHCII, CD4 and XCR1. 
A) Gating strategy of cells after digest, OptiPrep and Ox-62 enrichment. Single cells were gated in FSC and SSC, 
dead cells, stained with DAPI, as well as T and B cells were excluded from the analysis. DC were identified by the 
expression of MHCII and CD103. Two major DC subsets were analyzed for XCR1 and CD4 expression. B) 
Frequency of DC population among living cells C) Viability of spleen cells after respective enrichment steps. Error 





Figure 8: Two major DC subsets can be identified in rat spleens. Rat spleens were digested with 
Collagenase D and Dnase I followed by OptiPrep density centrifugation. DC were gated by excluding dead, 
CD3+ and CD45RA+ cells. Two major DC subsets were differentiated by the expression of CD4 (dotplot). MHCII++ 
populations were gated separately. For each analyzed surface marker (red curve), a fluorescence minus one 




4.1.2 Identification of XCR1 and XCL1 expression in Xcr1+/+ and Xcr1-/- rats 
To examine receptor function in the context of a RCMV infection, an Xcr1 knockout Sprague 
Dawley rat was generated in collaboration with Michael Bader at the Max Delbrück Center 
using CRISPR/Cas technology (Bauer 2018). The transgenic animals showed a deletion of 
169 bp in exon 2 of Xcr1. During heterozygous breeding, genotypes were verified by PCR 
with primers binding at positions 3204 and 3659 of Xcr1. Xcr1+/+ rats showed a band at 456 
bp, whereas Xcr1-/- rats had a product size of 287 bp. Heterozygous rats (Xcr1+/-) showed two 
bands at respective heights (Figure 9 A). Analysis of XCR1 surface expression confirmed 
that the deletion of 169 bp in Xcr1 led to a loss of the protein (Figure 9 B).  
 
Figure 9: Genotyping and XCR1 expression in Xcr1-/- and Xcr1+/+ rats. (A) Genotyping of Xcr1. PCR was 
performed with DNA obtained from ear biopsies. Xcr1+/+ rats showed a product size of 456 bp and Xcr1-/- rats 
showed a product size of 287 bp. B) XCR1 expression on DC from Xcr1+/+ and Xcr1-/- rats. 
Furthermore, XCL1 production of splenic leukocytes was determined in Xcr1+/+ and Xcr1-/- 
rats. For this purpose, spleen cells were isolated and stimulated with PMA and ionomycin 
followed by intracellular staining of XCL1. Gates were set on T cells, NKT cells, CD161+ and 
CD161++ NK cells (Figure 10 A). T cells were further gated on CD4+ and CD8+ T cells (gating 
not shown). Flow cytometry analysis revealed that without significant differences between 
Xcr1+/+ and Xcr1-/- rats, about 20% of CD8+ T cells, 30% of CD161++ NK cells and 60% of 
NKT cells produced XCL1. Only 3% of CD4+ T cells expressed XCL1 (Figure 10 B). The 
CD161+ NK cell population almost completely disappeared after stimulation with PMA and 
ionomycin in Xcr1+/+ as well as in Xcr1-/- rats and consequently was not included in the XCL1 





Figure 10: XCL1 expression of stimulated spleen cells from Xcr1+/+ and Xcr1-/- rats. Isolated spleen cells 
were stimulated with 20 ng/ml PMA and 1 µg/ml ionomycin for 5 h followed by intracellular staining of XCL1. A) 
Cells were gated on T cells (CD3+), NKT cells (CD3+ CD161+) and NK cells (CD161+ and CD161++). B) XCL1 
expression in CD4+ and CD8+ T cells, NK cells (CD161++) and NKT cells. C) Frequency of CD161+ and CD161++ 
NK cells of Xcr1+/+ rats as representative, with and without stimulation. Error bars represent mean ± SD, n = 4/5.  
4.1.3 RCMV-B attracts DC from Xcr1+/+ and Xcr1-/- rats 
As it has been shown that RCMV-E encodes a chemokine that attracts XCR1+ DC (Geyer et 
al. 2014), it was examined whether this population is also attracted by RCMV-B compared 
with the Xcr1 knockout strain. Therefore, REF were infected with RCMV-B at an MOI of 10. 
48 hpi DC were isolated from spleens of Xcr1+/+ and Xcr1-/- rats and prepared for a 
chemotaxis assay using viral supernatants. To analyze background migration, supernatants 
of uninfected REF served as a control (Mock). DC (MHCII+ CD103+) were separated into two 
subsets according to the expression of CD4. As shown in Figure 11, 9-10.6% of CD4- DC 
from both Xcr1+/+ and Xcr1-/- rats migrated towards mock-infected supernatants which was 
considered as background migration. In contrast, viral supernatant attracted 26.7% of CD4- 
DC from Xcr1+/+ and 22.2% from Xcr1-/- rats (Figure 11 A). The Xcr1 knockout strain exhibited 
slightly reduced but not complete loss of chemotactic activity towards RCMV-B. In contrast, 
CD4+ DC were not attracted by viral supernatants, since the migration rate was comparable 





Figure 11: Chemotaxis of DC from Xcr1+/+ and Xcr1-/- rats to supernatants of RCMV-B infected REF. REF 
were infected at an MOI of 10 for 48 h. Each transwell contained supernatant of RCMV-B infected or mock-
infected REF in the lower chamber. 5*105 of Ox-62 enriched and stained DC were added to the upper chamber of 
a transwell system. After 2.5 h of incubation, cells that migrated to the lower chamber were analyzed by flow 
cytometry. A) Migration of CD4- DC. B) Migration of CD4+ DC. Error bars represent mean ± SD, n = 5. 
4.1.4 DC, T cells and B cells can be identified in salivary glands 
To investigate the presence of DC and different lymphocytes in salivary glands, an organ 
digestion and cell isolation protocol was established. Submandibular and parotid glands (in 
this work referred to as salivary glands) were pooled and processed as described in section 
3.4.5. Leukocytes were gated in FSC and SSC and dead cells were excluded from the 
analysis. B and T cells that were further divided in CD8+ and CD4+ subsets and DC were 
identified (Figure 12 A). The DC frequency increased from 0.2% to 0.6% of all living cells 
(Figure 12 C). The fluorescence minus one (FMO) control confirmed that the MHCII+ CD103+ 





Figure 12: Identification of leukocytes in salivary glands. Submandibular and parotid glands from three SD 
rats were isolated, mashed, digested and enriched by using NycoPrep®. Several surface receptors were stained 
with fluorophore-coupled antibodies. A) Single cells were gated in FSC and SSC and dead cells stained with 
DAPI were excluded from the analysis. T cells (CD3+) were divided into CD4+ and CD8+. B cells were gated 
according to CD45RA expression and DC were identified by the expression of MHCII and CD103. B) DC after 
digest and NycoPrep® enrichment. To exclude unspecific signal, a fluorescence minus one (FMO) control, 
without the antibody against CD103, was performed. C) Bar chart of DC frequency after digest and NycoPrep® 
enrichment.  
4.2 Ex vivo infection of DC 
4.2.1 RCMV-E infects and replicates in rat DC 
In order to investigate whether RCMV replicates in DC, infection studies were carried out 
with splenic Ox-62 enriched cells. DC were infected at MOI 10 with recombinant RCMV-E 
carrying a gfp-cassette adjacent to e32 for 8, 16, 24 and 48 h. To examine if viral replication 
occurs, UV-inactivation at 1 J/m2 of recombinant virus was performed before infection. Mock-
infected cells served as a negative control (Figure 13). Figure 13 A depicts the GFP signal, of 
CD103+ MHCII+ cells, which was at 23.5% 8 hpi and increased to 59.2% at 16 hpi, 73.8% at 
24 hpi up to 87.9% at 48 hpi. Mock- and UV-infection showed no GFP signal. Dead cells 
were excluded from the analysis. Viability was decreasing in all Mock, RCMV-GFP and UV-
infected samples from 70.4-83% 8 hpi to 32.8-60.2% 16 and 24 hpi and finally dropped to 
20.4-39.4% 48 hpi (Figure 13 B). DC that were infected with UV-inactivated RCMV-E GFP 




RCMV-E GFP. In contrast, infection with RCMV-E GFP showed small differences compared 
to Mock though cultivation of DC was limited to 48 h since viability decreased to 39.4%. 
Gating on DC as described above was impeded because RCMV-E infection led to changes 
in the DC phenotype. The expression of MHCII was reduced from 70% of all living cells to 
20% at 48 hpi (Figure 13 C). Mock as well as UV-inactivated RCMV-E GFP had no influence 
on MHCII expression. In addition, a strong reduction of XCR1 surface expression was 
observed in infected as well as mock-infected DC. However, viral infection led to a more 
rapid reduction of XCR1 surface expression with 12% at 8 hpi, 1.7% at 16 hpi and 0.5-0.4% 
at 24 and 48 hpi (Figure 13 D) compared to Mock which was reduced from 32.5% at 8 hpi to 
19.5% at 16 hpi, 5.5% at 24 hpi and dropped to the same level as in infected DC to 0.7% at 
48 hpi. Infection with UV-inactivated virus showed the same trend as Mock but with lower 
expression rates.  
 
Figure 13: Infection of DC with RCMV-E GFP and UV-inactivated virus. Ox-62 enriched DC were infected with 
RCMV-E GFP and UV-inactivated RCMV-E GFP at an MOI of 10. Mock-infected cells served as a negative 
control. Expression of cell surface proteins was analyzed by flow cytometry after multi-color staining. Fixation was 
conducted with 2% (w/v) PFA. A) GFP signal in MHCII+ CD103+ DC. B) Cell viability was determined by staining 
cells with Pacific Orange (PacO) prior to fixation. C) MHCII expression within living cells. D) XCR1 expression 
within the CD103+ population. 
In order to confirm viral replication, intracellular expression of IE1 was detected after infection 
with both RCMV-E encoding vxcl1 (wt) and a mutant virus lacking the viral chemokine 
(vxcl1). Determination of IE1 expression at 8, 16 and 24 hpi confirmed the infection rates 




and RCMV-E vxcl1 (Figure 14 A). Here, viral infection did not affect cell viability (Figure 14 
B).  
 
Figure 14: RCMV-E wt and RCMV-E vxcl1 infect splenic DC ex vivo. Ox-62 enriched DC were infected with 
RCMV-E wt and RCMV-E vxcl1 mutant at an MOI of 10. Mock-infected cells served as a negative control. At 8, 
16 and 24 hpi intracellular IE1 was analyzed by flow cytometry after multi-color staining. Fixation was conducted 
with 2% (w/v) PFA and permeabilization with 0.5% (w/v) saponin. A) IE1 expression within the DC population. B) 
Viability of DC after infection. Error bars represent mean±SD, n = 3 independent experiments. 
At 8 hpi the expression of XCR1 was significantly reduced by 42% in RCMV-E wt and by 
32% in RCMV-E vxcl1 infected DC compared to mock-infected cells (Figure 15 A). At this 
time point the reduction of XCR1 was significantly higher in RCMV-E wt than in RCMV-
E vxcl1 infected DC. Furthermore, it is shown that both viruses led to reduced MHCII 
expression, from 70% of all living cells to 20% at 16 hpi and to 15% at 24 hpi (Figure 15 B). 
Compared to MHCII expression in fresh isolated DC, MHCII was first upregulated after 8 h. 
MHCII was constantly upregulated in mock-infected cells but was notably reduced in RCMV-
E infected cells (Figure 16). In addition, the expression of CD4 was reduced from 45% within 
the CD103+ population to 13% at 16 hpi and 8% at 24 hpi in infected DC (Figure 15 C). 
Therefore, the DC subsets could be only differentiated until 8 hpi because of the reduction of 
MHCII, CD4 and XCR1 surface expression. 
 
Figure 15: RCMV-E infection leads to changes in DC surface protein expression. Ox-62 enriched DC were 
infected with RCMV-E wt and RCMV-E vxcl1. Mock-infected cells served as a negative control. Expression of 
cell surface proteins was analyzed by flow cytometry after multi-color staining. Fixation was conducted with 2% 
(w/v) PFA. A) XCR1 expression within CD103+ cells. B) MHCII expression on DC within living cells. C) CD4 
expression on DC. Error bars represent mean ± SD., n = 3 independent experiments. Data were analyzed by one-





Figure 16: RCMV-E infection downregulates MHCII expression. Ox-62 enriched DC were infected with 
RCMV-E wt (red curve) and RCMV-E vxcl1 (yellow curve). Mock-infected cells served as a negative control 
(blue curve). Freshly isolated DC served as controls to demonstrate the initial state of expression (grey curve). 
Expression was analyzed by flow cytometry after multi-color staining. Fixation was conducted with 2% (w/v) PFA. 
One representative of 3 experiments is shown. 
Since the investigation of GFP or IE1 expression does not imply viral replication, RCMV-E wt 
infected DC were analyzed with ultrathin section transmission electron microscopy (EM) at 
24 hpi. EM analysis revealed cytoplasmic virus factories right next to deformed nuclei (Figure 
17 A and B). Furthermore, mature viral particles could be visualized outside the cell (Figure 
17 C). As replication and capsid formation is taking place in the nucleus, the identification of 
cytoplasmic virus factories indicated successful viral replication. 
 
Figure 17: Ultrathin section transmission electron microscopy of RCMV-E infected DC. Ox-62 enriched DC 
were infected with RCMV-E wt at an MOI of 10. 24 hpi DC were fixed in 2.5% (w/v) glutaraldehyde and embedded 
in 3% (w/v) low melting agarose, followed by preparing sections with a size of 60-70 nm. Images were recorded 
using a Veleta CCD camera (EMSIS). A) Overview of cytoplasmic virus and deformed nuclei, B) a cytoplasmic 
virus factory including viral capsids after nuclear egress and C) mature viral particle of RCMV-E. 
4.2.2 RCMV-E infection of DC alters their chemotactic activity 
After verifying RCMV-E replication in DC, it was investigated whether RCMV-E infection 
affects the migration behavior of DC. To do so, Ox-62 enriched DC were infected with 
RCMV-E wt and RCMV-E vxcl1 for 4 h, followed by a transwell assay with 100 ng/ml 
recombinant rXCL1 in the bottom well for another 2.5 h. Mock-infected DC were analyzed as 




in Figure 18 A, mock-infected CD4- DC migrated towards the host chemokine rXCL1 with a 
rate of 54% of input cells. In contrast, infection led to a significant, almost complete loss of 
chemotactic activity after both RCMV-E wt (to 8.4%) and RCMV-E vxcl1 (to 13.2%) infected 
DC (Figure 18 A). The reduction of chemotactic activity between both virus infections was not 
significant. Chemotaxis to the No Chemokine control ranged between 5-7.6% in all three 
samples. The CD4+ DC subset that mainly lacked XCR1 hardly showed migration at a rate of 
5-6%. Interestingly, mock-infected CD4+ DC showed 14% migration towards rXCL1 (Figure 
18 B). 
 
Figure 18: Chemotactic activity of RCMV-E infected DC towards rXCL1. Ox-62 enriched DC were infected 
with RCMV-E wt and RCMV-E vxcl1 with an MOI of 3 for 4 h at 37°C. Mock-infected cells served as negative 
control. After incubation the cell surface was stained with fluorophore-coupled antibodies. In order to investigate 
chemotactic activity, 2*105 of the incubated and stained DC were added to the upper chamber of a transwell 
system. Each transwell contained either 100 ng/ml rXCL1 or no chemokine in the lower chamber. After 2.5 h of 
incubation, cells that migrated to the lower chamber were analyzed by flow cytometry. A) Migrated CD4- DC, B) 
Migrated CD4+ DC. Two independent replicates were carried out in technical duplicates (n = 2). Error bars 
represent mean ± SD. Data were analyzed by one-way ANOVA and Dunnett's multiple comparison test (* 
p<0.0332; ** p<0.0021; *** p<0.0002; **** p<0.00001).  
4.2.3 RCMV-E infection leads to changes in the DC transcriptome profile 
To gain deeper insights in DC gene expression after RCMV-E infection, the DC 
transcriptome profile was analyzed by using a RNA sequencing technique. In this analysis, 
two aspects were determined: First, changes of transcribed genes in enriched DC after 
cultivation (Mock) and second, changes after infection with RCMV-E wt, RCMV-E vxcl1 and 
RCMV-E UV inactivated wt (here referred to as UV). In order to obtain a relatively high 
number of infected DC without decreased viability, DC were infected with a MOI of 3 for 24 h. 
To demonstrate DEG, RNA sequencing data were normalized on freshly isolated 
uncultivated DC, resulting in diagrams that depict fold changes. Figure 19 shows Venn-
diagrams that give an overview of the quantity of DEG. Figure 19 A indicates that 1513 
genes were upregulated considering Mock, RCMV-E wt, RCMV-E vxcl1 and UV. These 




were exclusively upregulated in the respective group, e.g., 13 in RCMV-E wt and 15 genes in 
RCMV-E vxcl1 infected DC (Figure 19 A). Figure 19 B shows that in total 2160 genes were 
downregulated. Mock, RCMV-E wt, RCMV-E vxcl1 and UV shared 869 downregulated 
genes. To get a better overview of the similarity between the test groups a heatmap of all 
DEG was generated with red colored upregulated and blue colored downregulated genes 
(Supplement 2). Automated clustering revealed that RCMV-E wt and RCMV-E vxcl1 
induced similar transcriptomic changes. The same applied for RCMV-E UV and Mock, 
indicating that not-replicating virus induced a similar phenotype as in mock-infected DC.  
 
Figure 19: Regulated genes in RCMV-E infected DC. Ox-62 enriched DC were infected with RCMV-E wt, UV-
inactivated RCMV-E and RCMV-E vxcl1. Mock-infected cells served as negative control. Gene expression was 
normalized to uncultivated DC. A) Venn-diagram of upregulated genes. B) Venn-diagram of downregulated 
genes. Differentially expressed genes predicted by SCORE with a fold change > 4, p ≤ 0.05, n = 3. 
To further analyze what type of genes are differentially expressed, the DEG list was 
integrated in the KEGG. Genes were mapped by pathways on molecular interactions, 
reaction and relation networks. KEGG creates a list of pathways where DEG are clustered. 
Using these overviews, DEG of interest were picked and clustered in a more detailed 
heatmap (Supplement 3). In addition, genes that are not categorized in KEGG were manually 
picked (Figure 20). The heatmap in Figure 20 depicts genes associated with antigen 
presentation that are differently transcribed in infected and mock-infected DC. On the one 
hand, Rab27a, Rac2 and the Tap gene Tap2 were downregulated in infected DC but 
upregulated in Mock and UV samples (Figure 20). On the other hand, Calr, Pdia3 and 
Sec22b were stronger upregulated in infected than in mock-infected DC (Supplement 4). 
Ccl17 was strongly downregulated in infected but massively upregulated in uninfected DC 
(Supplement 4). Ccl2, Ifnb1 and Ifng are three of the few genes that were upregulated in all 




stronger downregulated in infected than in mock- or UV-infected DC (Supplement 4). The 
maturation markers Cd86, Cd80, Cd40 and Ccr7 were upregulated during cultivation at 37°C. 
This upregulation was hampered by the infection with RCMV-E wt and RCMV-E vxcl1. 
Compared with RCMV-E wt Ccr7 and Cd40 were less impeded by the infection with RCMV-E 
vxcl1 (Figure 20). Genes related to migration were upregulated in all groups, including PI3K 
as well as Akt. However, this upregulation was stronger in mock-infected DC (Supplement 4).  
 
Figure 20: Heatmap of DEG of interest. Ox-62 enriched DC were infected with RCMV-E wt, UV-inactivated 
RCMV-E and RCMV-E vxcl1 for 24 h (MOI 3). Mock-infected cells served as a negative control. Expressed 
genes were normalized to uncultivated DC. Upregulated genes are shown in red, downregulated genes are 
depicted in blue. Differentially expressed genes were predicted by SCORE with a fold change > 4, p ≤ 0.05, n = 3.   
4.3 rXCL1 and vXCL1 interact with XCR1+ DC 
4.3.1 rXCL1 and RCMV-B and -E encoded vXCL1 share sequence similarities  
To further determine the homology of rXCL1 and vXCL1, sequence alignment was performed 
and XCL1 from human, mouse, rat was compared to vXCL1 of RCMV-E and RCMV-B. In 
rats XCL1 is the only known member of the -chemokines that binds solely XCR1. 




conserved parts, including the protein core, but also little variable parts regarding the N-
terminus and high variable sites regarding the C-terminus (Figure 21 A). XCL1 of Mus 
musculus, Homo sapiens and Rattus norvegicus consist of 114 AA. RCMV-B and RCMV-E 
are the only known viruses encoding a XCL1 homolog, in this work referred to as vXCL1 E 
and vXCL1 B, respectively. While vXCL1 B comprises 114 AA as its host, vXCL1 E consists 
of 115 AA. Both vXCL1 variants contain two AA gaps at positions 7 and 8 while having three 
additional AA at positions 98, 99 and 100 (Figure 21 A). Comparing the AA sequence of 
XCL1 from Rattus norvegicus (rXCL1) with vXCL1 E or vXCL1 B, similarity was 63.2% and 
65.5%, respectively. vXCL1 B and vXCL1 E shared 83.3% similarity (Figure 21 B).  
 
Figure 21: Protein alignment of XCL1 from different species and vXCL1 encoded by RCMV-E and RCMV-B. 
A) Amino acid (AA) sequence from Homo sapiens (NC_000001.11), Mus musculus (NM_008510), Rattus 
norvegicus (NC_005112.4), RCMV-E (NC_019559), and RCMV–B (KP202868). Identical AA are indicated by 
black background and similar AA by gray background. White background indicates no similarity in AA sequence. 
B) Distance matrix for depicted protein sequences generated by Geneious. 
4.3.2 rXCL1 and vXCL1 affect XCR1 surface expression 
To investigate whether vXCL1 and rXCL1 have a different impact on XCR1+ DC, Ox-62 
enriched splenocytes of Sprague Dawley rats were incubated with different concentrations of 




cells were stained with fluorophore-coupled antibodies to determine the DC phenotype. 
Incubation with either 0,5 or 25 ng/ml of recombinant chemokines revealed that 25-30% of all 
DC expressed XCR1 without any difference between rXCL1 and the vXCL1 variants (Figure 
22). 50 ng/ml of both vXCL1 variants slightly reduced the XCR1 surface expression. This 
reduction was strengthened after incubating with 100 ng/ml of vXCL1. In contrast, a 
comparable reduced XCR1 expression was only observed after incubation with 250 ng/ml of 
rXCL1. With higher amounts of chemokine, the receptor disappeared further from the cell 
surface. At a concentration of 500 ng/ml, XCR1 expression was reduced to 19.9% after 
incubation with rXCL1 and to 12.4% after incubation with vXCL1 E and vXCL1 B (Figure 22). 
 
Figure 22: XCR1 cell surface expression on CD4- DC after incubation with recombinant chemokines. 2*105 
Ox-62 enriched splenic DC were incubated for 4 h with 0, 5, 25, 50, 100, 250 or 500 ng/ml of recombinant rXCL1, 
vXCL1 E and vXCL1 B, respectively. DC (CD3- CD45RA- MHCII+ CD103+) were analyzed by flow cytometry after 
multicolor-staining. Dead cells were excluded by DAPI staining prior to measurement. One of three independent 
experiments are shown. 
4.3.3 Prior incubation of DC with rXCL1 and vXCL1 impairs chemotactic migration 
towards rXCL1 
Since XCL1 binding led to a reduced XCR1 surface expression, the chemotactic activity of 
DC to endogenous rXCL1 was investigated following a previous incubation with recombinant 
chemokine rXCL1 and vXCL1. Splenic DC of Lewis rats were isolated with Ox-62 beads and 
incubated with 500 ng/ml of rXCL1 and vXCL1 E, respectively, for 4 h at 37°C followed by a 
chemotaxis assay towards rXCL1. The input control showed that XCR1 disappeared from the 
surface due to incubation with the respective chemokines (Figure 23 A). A ligand-
independent reduction of XCR1 was observed as well which led to a low migration rate of 
7.4%. The control with no chemokine in the bottom well showed that there was unspecific 




reduction of migratory potential from 7.4% (Untreated) to 4% (rXCL1) and 2.8% (vXCL1), 
respectively, which represented the rate of unspecific migration (Figure 23 B).  
 
Figure 23: Chemotactic activity of CD4- XCR1+ DC after incubation with rXCL1 and vXCL1. Ox-62 enriched 
splenic DC were incubated with 500 ng/ml rXCL1 or vXCL1, respectively, for 4 h at 37°C. Cells incubated without 
chemokine served as a control (Untreated). After incubation the cell surface was stained with fluorophore-coupled 
antibodies. In order to investigate chemotactic activity, 2*105 of the incubated and stained DC were added to the 
upper chamber of a transwell. Each transwell contained 100 ng/ml rXCL1 or no chemokine in the lower chamber. 
After 2.5 h of incubation cells that migrated to the lower chamber were analyzed by flow cytometry. A) XCR1 
surface expression after 4 h incubation at 37°C. B) Migrated CD4- DC relative to the input cell number. Error bars 
represent mean ± s.e.m., n = 2 independent experiments were carried out in duplicates. Data were analyzed by 
one-way ANOVA and Dunnett's multiple comparison test (**, p < 0.005; ***, p < 0.0005).  
4.4 In vivo infection of Xcr1+/+ and Xcr1-/- rats with RCMV-B 
4.4.1 Viral spread of RCMV-B in Xcr1+/+ and Xcr1-/- rats 
The RCMV-E strain, that was used in above described ex vivo infection experiments (4.2), 
could not be successfully isolated from salivary glands 16 days after i.p. infection. Therefore, 
it was decided to perform the in vivo experiments with RCMV-B which is the second isolate 
classified as MuHV-8.  
To investigate whether XCR1 plays a role in viral dissemination 10-week old Xcr1+/+ and 
Xcr1-/- Sprague Dawley rats were infected i.p. with 1*106 pfu RCMV-B wt. As a control 1 ml 
PBS (Mock) was injected i.p. After 3, 5, 16 and 90 dpi salivary glands, liver, lung and spleen 
were collected for virus detection by TaqMan qPCR. To determine RCMV-B, a probe 
targeting gB was utilized. For a defined copy number of the gene of interest, a standard with 
100 -107 copies was used. To normalize the samples, copy numbers of gB were divided by 
copy numbers of c-myc.  
The highest amount of RCMV-B gB was detected in spleen, lung and liver at 5 dpi (Figure 
24). The median gB/c-myc ratio in spleen was 0.33 and 0.28 in Xcr1+/+ and Xcr1-/- rats, 
respectively. At 3, 16 and 90 dpi gb was hardly detectable in spleen (ratio < 0.004) (Figure 24 
A). The highest ratio in lung was also detected at 5 dpi though ratios were lower compared to 




in Xcr1+/+ than in Xcr1-/- (0.004) rats. At 16 dpi, the ratio in the lung decreased to 0.007 and 
0.002 in Xcr1+/+ and Xcr1-/- rats, respectively (Figure 24 B). In liver, median ratios were 
similar to lung with 0.011 and 0.016 Xcr1+/+ and Xcr1-/- rats at 5 dpi, respectively (Figure 24 
C). In salivary glands the highest viral load was detected at 16 dpi where the median ratio 
was 0.3 and 0.6 in Xcr1+/+ and Xcr1-/- rats, respectively. Although the median was lower in 
Xcr1+/+ rats, it has to be considered that two Xcr1+/+ rats showed a massively higher gB/c-
myc ratio with 7.6 (rat 28) and 9.3 (rat 30), whereas two of the Xcr1-/- rats showed an 
extremely low gB/c-myc ratio with 0.02 and 0.005 (rat 62; Figure 24 D). These findings could 
be confirmed by plaque assay (Figure 25). The median of pfu/ml was 8.1*104 and 5.1*104 in 
Xcr1+/+ and Xcr1-/- rats, respectively. Rat 28 that showed a gB/c-myc ratio of 7.6 exhibited 
7.3*105 pfu/salivary gland, rat 30 had a gB/c-myc ratio of 9.3 and 4.1*106 pfu/salivary gland. 
Further, rat 62 indicated a gB/c-myc ratio of 0.005 and 1.6*103 pfu/salivary gland. At 90 dpi, 
low ratios in salivary glands of both Xcr1+/+ and Xcr1-/- rats could be determined (Figure 24 
D). 
 
Figure 24: Detection of viral gB DNA after infection of Xcr1+/+ and Xcr1-/- rats with RCMV-B. 10-week-old 
male Sprague Dawley rats were infected with 1*106 pfu of RCMV-B wt. After 3, 5, 16 and 90 dpi, spleens (A), 
lungs (B), livers (C) and salivary glands (D) were collected and DNA was isolated, followed by TaqMan-qPCR 
with specific primers and probes targeting the viral gene gB and the host gene c-myc. Relative copy numbers of 
gB were normalized to the housekeeping gene c-myc. Results were obtained from 6 biological replicates in 





Figure 25: Titration of salivary glands of Xcr1+/+ and Xcr1-/- rats at 16 dpi. 10-week-old male Sprague Dawley 
rats were infected with 1*106 pfu of RCMV-B. 16 days post infection the left salivary gland was homogenized, 
diluted and put on REF. After 1 h cells were covered with Overlay-medium and one week later pfu were counted. 
Results were obtained from 6 biological replicates in technical duplicates. Numbers represent individual rat 28, 30 
and 62. Bars represent the median. 
4.4.2 Frequencies of leukocytes after infection with RCMV-B wt 
Following the investigation of RCMV-B wt dissemination in Xcr1+/+ and Xcr1-/- rats, 
frequencies of DC, B cells, T cells, NK cells and NKT cells were determined in blood, lymph 
nodes, salivary glands and spleens at 3, 5, 16 and 90 dpi. Supplement 2 depicts dot blots 
and the gating strategy for the different cell populations within the respective organs 
(Supplement 5). Only significant differences between infected and mock-infected as well as 
Xcr1+/+ and Xcr1-/- rats are described. An overview about all cell frequencies of all organs and 
timepoints are summarized in the supplements (Supplement 6-11). 
4.4.2.1 Three days post infection 
In blood and lymph nodes Xcr1+/+ and Xcr1-/- rats the frequency of CD8+ T cells was slightly 
decreased after infection (Figure 26 A and B). In lymph nodes of Xcr1+/+ rats the amount of 
DC was higher after infection compared to Mock. In lymph nodes of infected Xcr1-/- rats the 
frequency of DC was increased as well but was significantly lower than in infected Xcr1+/+ 
rats (Figure 26 C).  
In spleens the number of CD8+ T cells was significantly increased in infected Xcr1-/- from 
21% to 32% and not significantly increased in Xcr1+/+ rats from 19% to 22 (Figure 26 D). On 
the contrary, the frequency of CD4+ T cells was reduced in infected Xcr1-/- rats but not in 
Xcr1+/+ rats (Figure 26 E). The amount of NK cells was increased in the spleen of infected 
Xcr1-/- rats but not in Xcr1+/+ rats compared to the respective mock-infected animals (Figure 
26 F). The number of NKT cells in spleens was elevated in both Xcr1-/- and Xcr1+/+ rats after 
infection. The amount of B cells slightly dropped after infection of Xcr1+/+ and Xcr1-/- rats 





Figure 26: Frequency of leukocytes in RCMV-B and Mock infected Xcr1+/+ and Xcr1-/- rats at 3 dpi. 10- 
week-old male Sprague Dawley rats were infected with 1*106 pfu of RCMV-B or 500 µl PBS (Mock) for 3 days. 
Leukocytes were isolated from blood, lymph nodes and spleen. After surface staining, cells were gated on DC, 
CD8+ and CD4+ T cells, B cells, NK and NKT cells. A) Frequency of CD8+ T cells within the CD3+ population in 
blood. B) Frequency of CD8+ T cells within the CD3+ population in lymph nodes. C) Frequency of DC within living 
cells in lymph nodes. Orange: CD4- DC, turquois: CD4+ DC D) Frequency of CD8+ T cells within the CD3+ 
population in spleen. E) Frequency of CD4+ T cells within the CD3+ population in spleen. F) Frequency of NK cells 
within living cells in spleen. G) Frequency of NKT cells within living cells in spleen. H) Frequency of B cells within 
living cells in spleen. Error bars represent mean ± SD, n = 6 rats. Data were analyzed by one-way ANOVA and 
Tukey’s multiple comparison test (ns = not significant; * p<0.0332; ** p<0.0021; *** p<0.0002; **** p<0.00001). 
4.4.2.2 Five days post infection 
After five days of infection, higher frequencies of NKT cells could be detected in the blood 
and lymph nodes of Xcr1+/+ and Xcr1-/- rats after infection (Figure 27 A and C). In lymph 
nodes an increased rate of NK cells could be detected as well after infection (Figure 27 B).  
In spleen several changes in cell frequency were observed. DC frequency was lower in both 
infected Xcr1+/+ and Xcr1-/- rats compared to Mock (Figure 27 C). The number of NK cells 
was increased in infected Xcr1-/- rats compared to Mock. In infected Xcr1+/+ rats the NK cell 
rate increased not as high as in infected Xcr1-/- rats (Figure 27 F). Like their counterpart, NKT 
cell frequency was significantly higher in spleens of infected rats (Figure 27 G). Furthermore, 
the frequency of B cells was significantly decreased in Xcr1+/+ and Xcr1-/- rats after infection 





Figure 27: Frequency of leukocytes in RCMV-B and Mock infected Xcr1+/+ and Xcr1-/- rats at 5 dpi. 10-
weeks-old male Sprague Dawley rats were infected with 1*106 pfu of RCMV-B or 500 µl PBS (Mock) for 5 days. 
Leukocytes were isolated from blood, lymph nodes and spleen. After surface staining, cells were gated on DC, 
CD8+ T cells, B cells, NK and NKT cells. A) Frequency of NKT cells within living cells in blood. B) Frequency of 
NK cells within living cells in lymph nodes. C) Frequency of NKT cells within living cells in lymph nodes. D) 
Frequency DC within living cells in spleen. Orange: CD4- DC, turquois: CD4+ DC E) Frequency of CD8+ T cells 
within the CD3+ population in spleen. F) Frequency of NK cells within living cells in spleen. G) Frequency of NKT 
cells within living cells in spleen. H) Frequency of B cells within living cells in spleen. Error bars represent mean ± 
SD, n = 6 rats. Data were analyzed by one-way ANOVA and Tukey’s multiple comparison test (ns = not 
significant; * p<0.0332; ** p<0.0021; *** p<0.0002; **** p<0.00001). 
4.4.2.3 Sixteen days post infection 
After 16 days of infection, significant changes of cell frequencies were observed in salivary 
glands. There, the frequency of CD8+ T cells was increased to 60% and 58% in infected 
Xcr1+/+ and Xcr1-/- rats, respectively, compared to Mock with 21% and 11% (Figure 28 A). DC 
frequency was 5.2 times higher in infected Xcr1+/+ rats (0.81%) and only 3.7 times higher in 
Xcr1-/- rats (0.33%) (Figure 28 B). The increased number of DC in salivary glands and the 
difference between both genotypes was more noticeable in the representative dot plots in 
Figure 29 that shows 2724 events in infected Xcr1+/+ rats and 1150 events in infected Xcr1-/- 
rats (event number is the mean of all 6 replicates). The NK cell frequency was increased in 
salivary glands of infected Xcr1+/+ rats, whereas infected Xcr1-/- rats showed no significant 
elevated NK cell frequency (Figure 28 C). In addition, the NKT cell frequency escalated in 
salivary glands of infected Xcr1+/+ and Xcr1-/- rats and was significantly higher in infected 




In blood of infected Xcr1+/+ rats a higher amount of NKT cells was observed compared to 
Mock. The elevated NKT cell frequency in blood of infected Xcr1-/- rats was significantly lower 
than in Xcr1+/+ rats (Figure 28 E). In lymph nodes, the NKT cell frequency was increased in 
both infected Xcr1+/+ and Xcr1-/- rats (Figure 28 F). In spleen the DC frequency was still 
reduced after infection (Figure 28 G). 
 
Figure 28: Frequency of leukocytes in RCMV-B and Mock infected Xcr1+/+ and Xcr1-/- rats at 16 dpi. 10-
week-old male Sprague Dawley rats were infected with 1*106 pfu of RCMV-B or 500 µl PBS (Mock) for 16 days. 
Leukocytes were isolated from blood, lymph nodes, salivary glands and spleen. After surface staining, cells were 
gated on DC, CD8+ T cells, NK and NKT cells. A) Frequency of CD8+ T cells within the CD3+ population in 
salivary glands. B) Frequency DC within living cells in salivary glands. Orange: CD4- DC, turquois: CD4+ DC C) 
Frequency of NK cells within living cells in salivary glands. D) Frequency of NKT cells within living cells in salivary 
glands. E) Frequency of NKT cells within living cells in blood. F) Frequency of NKT cells within living cells in 
lymph nodes. G) Frequency DC within living cells in spleen. Error bars represent mean ± SD, n = 6 rats. Data 
were analyzed by one-way ANOVA and Tukey’s multiple comparison test (ns = not significant; * p<0.0332; ** 






Figure 29: Dotplot of DC population within living cells at 16 dpi. 10-week-old male Sprague Dawley rats were 
infected with 1*106 pfu of RCMV-B or 500 µl PBS (Mock) for 16 days. Leukocytes were isolated from salivary 
glands. After surface staining, cells were analyzed for MHCII+ and CD103+ expression and further gated on CD4 
and XCR1 to analyze both DC subsets. Dotplot represents one of 6 biological replicates. 
4.4.2.4 Ninety days post infection 
After 90 days of infection most of the cell frequencies were balanced and comparable to 
mock-infected rats. However, in salivary glands of infected Xcr1+/+ rats a maintained 
increased CD8+ T cell frequency was determined. Interestingly, this was not the case for 
infected Xcr1-/- rats (Figure 30 A). Furthermore, the frequency of NKT cells in salivary glands 
was still higher after 90 days of infection in both Xcr1+/+ rats and Xcr1-/- rats (Figure 30 B). In 
spleens the DC rate was, as observed for the other time points, still lower after infection 






Figure 30: Frequency of leukocytes in RCMV-B and Mock infected Xcr1+/+ and Xcr1-/- rats at 90 dpi. 10-
week-old male Sprague Dawley rats were infected with 1*106 pfu of RCMV-B or 500 µl PBS (Mock) for 90 days. 
Leukocytes were isolated from salivary glands and spleen. After surface staining, cells were gated on DC, CD8+ T 
cells and NKT cells. A) Frequency of CD8+ T cells within the CD3+ population in salivary glands. B) Frequency of 
NKT cells within living cells in salivary glands. C) Frequency DC within living cells in salivary glands. Orange: 
CD4- DC, turquois: CD4+ DC Error bars represent mean ± SD, n = 6 rats. Data were analyzed by one-way 
ANOVA and Tukey’s multiple comparison test (ns = not significant; * p<0.0332; ** p<0.0021; *** p<0.0002; **** 
p<0.00001). 
4.5 Generation of a RCMV-B vxcl1 deletion mutant 
In order to perform functional analysis on RCMV-B vXCL1, a RCMV-B vxcl1 deletion mutant 
was generated with the genetic engineering technique CRISPR/Cas. A vector containing 
Cas9 and primer sequences that recognize vxcl1 of RCMV-B was provided by Robert Jan 
Lebbink (UMC Utrecht). Following limiting dilution promising mutants were cultivated and 
diluted again for plaque purification followed by another sequencing screening. The chosen 
mutant was characterized by a cytosine insertion at position 161 in vxcl1, resulting in a 
frameshift with a premature stop-codon (Figure 31 A). To verify that vXCL1 lacks translation 
supernatants of infected REF with different clones of the second limited dilution were tested 
by ELISA (Figure 31 B). Compared with positive controls including a RCMV-B stock and a 
supernatant of RCMV-B wt infected REF, the selected mutants had the same absorbance 
value as supernatants of mock-infected cells. For additional confirmation that the introduced 




in REF infected with RCMV-B wt and RCMV-B vxcl1 for 24 h by intracellular staining and 
flow cytometry. 3 h prior to fixation cells were treated with brefeldin A to inhibit vesicular 
transport. RCMV-B vxcl1 showed a dim signal for vXCL1 compared to mock-infected cells, 
but lower than RCMV-B wt (Figure 31 C).  
 
Figure 31: CRISPR/Cas generated RCMV-B vxcl1. REF were transfected with CRISPR/Cas vectors and 
infected with RCMV-B wt. After double plaque purification, single plaques were sequenced and characterized. A) 
Sequence alignment of vxcl1 from RCMV-B wt and RCMV-B vxcl1 clone C11. B) Supernatants (SN) of single 
plaques were tested in ELISA with mock-infected SN as a negative and viral SN as well as RCMV-B stock as 
positive controls. C) Intracellular staining of vXCL1 in infected REF (MOI 5, 24 hpi) with RCMV-B wt and RCMV-B 
vxcl1 C11.  
4.6 In vivo infection of wildtype rats with RCMV-B wt and RCMV-B vxcl1 
4.6.1 Viral dissemination 
To examine the function of vXCL1 in vivo and to address whether vXCL1 is used for viral 
dissemination, 9-week-old Lewis rats (Xcr1+/+) were infected i.p. with 1*106 pfu of RCMV-B wt 
and RCMV-B vxcl1, respectively. 16 dpi, salivary glands, liver, lung and spleen were 
collected for virus detection by TaqMan qPCR. The gB/c-myc ratio was very low (<0.001) in 




RCMV-B wt was 13 fold higher than the median of RCMV-B vxcl1 in spleen, 11 fold higher 
in liver and 7 fold higher in the lung (Figure 32 A). In salivary glands the ratio of RCMV-B 
vxcl1 was low with a median of 0.001. In comparison, the median ratio of RCMV-B wt was 
170 times higher (Figure 32 B). These results correspond to the plaque assay of 
homogenized salivary glands. Here, RCMV-B wt showed 8.2*103 pfu/salivary gland, whereas 
for RCMV-B vxcl1 only 1.9*102 pfu/salivary gland could be detected (Figure 32 C).  
 
Figure 32: Detection of viral gB DNA after infection with RCMV-B wt and RCMV-B vxcl1. 9-week-old male 
Lewis rats were infected with 1*106 pfu of RCMV-B wt or RCMV-B vxcl1, respectively. After 16 dpi, spleen, lung, 
liver (A) and salivary glands (B) were collected and DNA was isolated, followed by TaqMan-qPCR with specific 
primers and probes targeting the viral gene gB and host gene c-myc. Relative copy numbers of gB were 
normalized to the housekeeping gene c-myc. C) The left salivary gland was homogenized and diluted on REF. 
After 1 h cells were covered with Overlay-medium and one week later pfu were counted. Results were obtained 
from 3 biological replicates in technical duplicates. Bars represent the median. 
4.6.2 Frequencies of leukocytes after RCMV-B wt and RCMV-B vxcl1 infection 
To further investigate whether the deletion of vXCL1 has an impact on the migratory behavior 
of leukocytes, DC, T cells and B cells, NK cells as well as NKT cells were analyzed in blood, 




4.6.2.1 Dendritic cells 
The highest DC frequency ranging from 5-6% was determined in spleen from mock- and 
RCMV-B vxcl1 infected animals. In comparison, the DC frequency in the spleen of RCMV-B 
wt infected rats was lower (3.9%, Figure 33 A).  
In blood and lymph nodes there was no significant difference in DC frequency between 
mock-, RCMV-B wt and RCMV-B vxcl1 infected rats. In salivary glands the frequency was 
significantly increased from 0.08% (Mock), to 0.3% in RCMV-B wt and 0.15% in RCMV-B 
vxcl1 infected rats. Here, the increase in DC frequency was significantly higher in RCMV-B 
wt compared to RCMV-B vxcl1 infected rats (Figure 33 A).  
4.6.2.2 T cells 
The frequency of CD8+ T cells was significantly increased to 3.1% in salivary glands of 
RCMV-B wt infected rats compared to Mock with 0.18% and RCMV-B vxcl1 infected rats 
with only 0.7% (Figure 33 B). In spleen the frequency was 2.5 higher in RCMV-B wt and 2 
times higher in RCMV-B vxcl1 infected rats. In blood and lymph nodes there was no notable 
difference between the three groups. Infection with both virus variants did not change the 
frequency of CD4+ T cells compared to Mock (Figure 33 C). 
4.6.2.3 NK and NKT cells 
NK cells were differentiated into a CD161 high (CD161++) and low (CD161+) expressing 
population. RCMV-B infection had no influence on the frequency of CD161+ NK cells. In 
contrast, the CD161++ NK population was strongly influenced by the infection.  
In blood the CD161++ frequency escalated from 3.3% (Mock) to 7.2% in RCMV-B wt and to 
5.5% in RCMV-B vxcl1 infected rats (Figure 33 E). In salivary glands the frequency was 
increased from 0.4% (Mock) to 2% in RCMV-B wt and 0.96% in RCMV-B vxcl1 infected 
rats. In spleen the CD161++ frequency doubled after infection with RCMV-B wt and RCMV-B 
vxcl1.  
NKT cells were as well affected by the infection. In blood the frequency of NKT cells was 2.3 
and 1.75 times higher in RCMV-B wt and RCMV-B vxcl1 infected rats, respectively (Figure 
33 G). In salivary glands the NKT cell frequency went up to 2.1% in RCMV-B wt infected rats 
which is higher than in RCMV-B vxcl1 infected rats with 0.8% and Mock with 0.3%. In 
spleen the rate of NKT cells increased by the factor of 2.7 and 2.2 in RCMV-B wt and RCMV-




4.6.2.4 B cells 
Also B cells were influenced by RCMV-B infection. The frequency of B cells was reduced in 
lymph nodes by the factor of 1.6 and 1.3 in RCMV-B wt and RCMV-B vxcl1 infected rats, 
respectively. In spleen the reduction of B cells was more notable. There, the frequency 
decreased from 44.5% to 19.7% in RCMV-B wt and 26.5% in RCMV-B vxcl1 infected rats 








Figure 33: Frequencies of cell populations after infection with RCMV-B wt and RCMV-B vxcl1. 9-week-old 
male Lewis rats were infected with 1*106 pfu of RCMV-B wt or RCMV-B vxcl1, respectively. Leukocytes were 
isolated from blood, lymph nodes, salivary glands and spleen. After surface staining, cells were gated to analyze 
dendritic cells (A), CD8+ T cells (B), CD4+ T cells (C), B cells (D), NK CD161+ (E), NK CD161++ (F) and NKT cells 
(G). Frequency within living cells is shown. Error bars represent mean ± SD, n = 3 rats. Data were analyzed by 
one-way ANOVA and Tukey’s multiple comparison test (ns = not significant; * p<0.0332; ** p<0.0021; *** 






5.1 Identification of splenic rat DC subsets 
DC play a crucial role in recognizing pathogens, presenting antigens and inducing immune 
responses. To manage these different functions DC comprise phenotypically and locally 
distinct subsets. The observation that DC with apparently similar functions have distinct 
phenotypes in lymphoid tissues versus to those in peripheral organs, complicates the 
classification of DC. Another complicating issue is that markers of a particular cell subset are 
not consistent across species (Guilliams et al. 2014, Gurka et al. 2015). According to the DC 
nomenclature proposed in 2014, mouse and human conventional DC (cDC) are divided into 
two types (cDC1 and cDC2), both originated from a common DC precursor (Guilliams et al. 
2014, Naik et al. 2007). To include immature rat DC into that classification, the surface 
expression of different markers was investigated subsequently after enrichment. As in all 
mammals, rat DC lack the expression of T and B cell lineage markers. Two major DC 
subsets were determined: MHCII+ CD103+ CD4- XCR1+ CD11b/c+ CD172a(+) CD54+ and 
MHCII+ CD103+ CD4+ XCR1- CD11b/c+ CD172a+ CD54+ DC. A recent suggestion revealed 
that mouse cDC can be universally subdivided into XCR1+ and CD172a+ (SIRP) DC (Gurka 
et al. 2015). In rats, however, the expression of CD4 allows the separation of the two major 
subsets (Liu et al. 1998). The CD4+ rat DC co-express CD172a and CD4- DC express XCR1 
(Figure 8). XCR1 is described in mouse and human as a marker for Type 1 and cross-
presenting cDC (Crozat et al. 2010, Dorner et al. 2009). Cross-presenting murine DC are 
further characterized by the expression of CD8. In contrast, CD8 is not expressed on cross-
presenting human DC and was not expressed on spleen derived rat DC (Shortman and Liu 
2002, Vremec et al. 2000). Nevertheless, CD4- rat DC are thought to be the equivalent to 
murine CD8+ DC (Hubert et al. 2006, Yrlid and Macpherson 2003). The expression of XCR1 
on CD4- DC and CD172a on CD4+ DC supports the idea, to classify rat CD4- DC as cDC1 
and CD4+ DC as cDC2.  
In addition another two dim populations were identified with higher expression of MHCII and 
CD86. CD86 is a costimulatory molecule that interacts with CD28 on T cells, leading to T cell 
activation and tolerance. Since CD86 plays a role in antigen presentation, it is considered as 
a DC maturation marker (Greenwald et al. 2005, Lenschow et al. 1996). Furthermore, the 
MHCII++ CD4- DC subset showed lower XCR1 expression. Reduced XCR1 expression was 
previously observed in mouse upon DC activation (Gurka et al. 2015). The higher CD86 and 
MHCII expression and the reduction of XCR1 indicate that DC become activated during the 




Another interesting observation was made concerning the ratio between both DC subsets. 
After density centrifugation the frequency of CD4- XCR1+ DC within the CD103+ population 
was 30%, whereas the CD4+ XCR1- DC frequency was 55% (Figure 7). Since DC 
frequencies can differ between rat strains, the comparison between species is not useful 
(Hubert et al. 2006). However, the relative distribution of CD4- DC and CD4+ DC changed 
after Ox-62 microbead enrichment to 54% and 37%, respectively. Investigation of the flow 
through after positive selection revealed a loss of CD4+ DC (data not shown). Interestingly, 
CD4- DC were shown to have higher expression of CD103 (Supplement 1). Despite 
experiments using higher amounts of microbeads the loss of the CD4+ subpopulation could 
not be prevented. This leads to the assumption that most of the Ox-62 microbeads were 
bound by CD4- DC. 
5.2 XCL1 is secreted by CD161++ NK cells, NKT cells and CD8+ T cells  
Upon stimulation, leukocytes secrete chemokines to attract effector cells, including DC and T 
cells, to the site of inflammation. To complement the knowledge about the expression of the 
only known -chemokine on single cell level, XCL1 production was investigated in rats. After 
5 h stimulation with ionomycin and PMA, about 20% of CD8+ T cells produced XCL1. In 
comparison, the frequency measured in mouse was between 25% and 40% (Dorner et al. 
2003). In accordance to mouse, the frequency of CD4+ T cells expressing XCL1 was 3% in 
rats. The identification of NK cell populations was impeded, since the stimulation altered the 
CD161 expression. Here, the CD3- CD161+ population almost completely disappeared after 
stimulation and, thus, could not be included in the XCL1 expression analysis. However, the 
frequency of XCL1 producing CD161++ NK cells was 34% which was just the half of the 
frequency that was measured in BALB/c and C57BL/6 mice (Dorner et al. 2003). There are 
no published single cell data about XCL1 expression in NKT cells obtained from spleen. In 
rat spleen, however, these cells were identified as the highest XCL1 producer after 
stimulation with ionomycin and PMA (Figure 10). These data correspond to recent published 
invariant NKT cells from liver that expressed as well higher amounts of XCL1 than adaptive T 
cells and NK cells (Woo et al. 2018).  
As already discussed for DC classification, the comparisons between species might be not 
useful for a better understanding of the function of rat XCL1. The different expression values 
between species may have several reasons, like the age of the animals or the procedure of 
cell isolation. Nevertheless, the most interesting issue is that leukocytes expressing XCL1 
share a cytotoxic ability across species. NK cells and NKT cells represent actors of the 
innate immune response. Early upon infection with MCMV and Listeria NK cells were shown 




(Dorner et al. 2002, Dorner et al. 2004, Dorner et al. 2003). On the site of adaptive immune 
response, CD8+ T cells dominantly secreted XCL1. This underlines the idea that DC, 
controlled by the XCL1-XCR1 axis, are a communication platform between innate and 
adaptive immune response. In addition, XCR1+ DC may be the ideal communication partner 
for CD8+ T cells, since they cross-present antigens and induce a proliferative monoclonal 
antigen specific T cell clone that combats pathogen infected cells (Kroczek and Henn 2012).   
5.3 RCMV interference with DC 
5.3.1 RCMV attracts and productively infects splenic DC ex vivo  
DC are attracted by innate and adaptive immune cells to the site of infection to take up 
antigens that will be presented by MHCI or MHCII to CD8+ or CD4+ T cells, respectively. This 
migratory potential could be exploited by RCMV. On the one hand, DC could be infected and 
used as distribution vehicles to access other organs or cells. On the other hand, the virus 
could remain in DC and subvert antigen presentation to escape the immune response 
(Banchereau et al. 2000).  
RCMV-E and RCMV-B are unique in encoding the -chemokine homolog vXCL1 which solely 
chemoattracts XCR1+ DC (Bauer et al. 2020, Geyer et al. 2015, Geyer et al. 2014). 
Interestingly, when XCR1 is knocked out, the CD4- DC population was still attracted by 
RCMV-B supernatant, though with reduced frequency (Figure 11). Since chemokines are 
promiscuous, binding to more than one receptor (Thiele and Rosenkilde 2014), one 
assumption would be that vXCL1 binds to another chemokine receptor. Actually, DC 
chemotaxis could be mediated by several chemokine receptors, like CCR1, CCR2, CCR5, 
CCR6, CXCR1 and CXCR2 (Sozzani et al. 2001). However, binding studies demonstrated 
that recombinant rXCL1 and vXCL1 did not bind to CD4- DC from Xcr1-/- rats which proves 
that XCR1 is the only receptor for XCL1 (Bauer 2018). These findings suggest that RCMV 
encodes other chemokines that attract CD4- DC.  
Chemokine mimicry is a common phenomenon among herpesviruses. Except for HCMV 
UL130 and Herpes simplex virus 2 gL that are described as C type chemokine hybrids 
(Malkowska et al. 2013, Wyrwicz and Rychlewski 2007), MuHV-8 vXCL1 is the only known C 
type chemokine (Geyer et al. 2014). HCMV UL130 acts as a membrane anchored ligand and 
is part of a cell-entry pentameric complex. This complex, additionally composed of gH, gL, 
UL131 and UL128, is essential for the infection of leukocytes, endothelial cells and epithelial 
cells (Gerna et al. 2005, Wang and Shenk 2005). A functional homolog to UL128 was 
identified in MCMV, m131/m129 (MCK-2), that promotes infection as part of a trimeric 




same genomic organization as MCK-2 which consists of two syntenic ORF (Voigt et al. 
2005). Hence, it is suggested that ECK-2 executes the same function as MCK-2. It was 
reported that MCK-2 deficient virus establishes a lower viral burden in mouse salivary glands 
which is the central reservoir for viral latency and transmission (Jordan et al. 2011). 
Consequently, MCK-2 is necessary for the infection of salivary glands but was dispensable 
for the infection of other organs (Fleming et al. 1999, Jordan et al. 2011). Furthermore, MCK-
2 was shown to mobilize and recruit myeloid progenitor cells to facilitate viral dissemination 
(Noda et al. 2006). To date no specific receptor has been identified but recent studies 
revealed that MCK-2 is an atypical viral chemokine that binds to glycosaminoglycans 
(Pontejo and Murphy 2017). On this basis it appears possible that CD4- DC of Xcr1-/- rats 
were attracted by ECK-2. Additionally, CMV infected fibroblasts could secrete endogenous 
chemokines, including CCL5 (Michelson et al. 1997) that may induce DC migration. By 
contrast, the CD4+ DC subset of both Xcr1+/+ and Xcr1-/- rats was not attracted by 
supernatants of RCMV-B infected REF (Figure 11). Thus, it appears that RCMV, by encoding 
vxcl1, has the intention to only attract CD4- XCR1+ DC. If one assumes that this population 
equals the cDC1 subset of Guilliam’s nomenclature, it might be possible that RCMV-E 
evolved a strategy to directly interact with potentially cross-presenting DC which could result 
in a distracted antigen specific cytotoxic immune response.  
The interaction with DC function is a strategy used by a number of viruses to elude the 
immune system. Whereas the infection with measles virus abrogates the ability of DC to 
stimulate the proliferation of naïve allogeneic CD4+ T cells (Grosjean et al. 1997), HIV uses 
DC for dissemination (Wu and KewalRamani 2006). For HIV it might be more beneficial to 
not replicate in DC until they reach their T helper subset in which they efficiently replicate 
(Granelli-Piperno et al. 1999). In contrast to HIV, successful RCMV-E replication could be 
shown in both CD4- and CD4+ DC. Since it is known that MCMV and HCMV infect DC, it was 
not surprising that RCMV behaves as its orthologs (Andrews et al. 2001, Jahn et al. 1999, 
Moutaftsi et al. 2002). RCMV-E replication was demonstrated by the identification of 
cytoplasmic virus factories by electron microscopy (Figure 17). Since RCMV has a broad cell 
tropism it was possible that both DC populations could be infected in vitro even though only 
CD4- DC were attracted by RCMV-B. Regardless of infection, the viability of DC decreased 
after 24 h. It is known that full matured DC die by apoptosis after interaction with other 
lymphocytes (Hou and Van Parijs 2004). By using DC for its own advantage RCMV might be 
under pressure to maintain DC viability. This was already described for MCMV that protects 
DC from apoptosis (Andoniou et al. 2004). However, ex vivo RCMV-E infection did not 




5.3.2 RCMV-E infection affects DC maturation and migratory ability towards rXCL1 
To elucidate the relevance of RCMV infection with respect to DC function, the expression of 
surface proteins was investigated. After 8 hpi a transient increase of MHCII was observed 
which remained in mock-infected DC but decreased in DC infected with RCMV-E 16 hpi 
(Figure 16). In MCMV studies an upregulation was also observed for MHCI, CD40, CD54 
and CD86 (Andrews et al. 2001). Additionally, UV-inactivated RCMV-E did not influence the 
downregulation of MHCII 16 hpi (Figure 13). Due to these findings it appears possible that 
the initial activation of MHCII 8 hpi was a consequence of the normal DC response to a 
pathogen. However, unlike other pathogens, replicating RCMV-E was able to subvert this 
activation, resulting in a downregulation of MHCII expression. vXCL1 had no influence on 
surface protein expression since RCMV-E vxcl1 showed the same effects as RCMV-E wt.  
To get further insights into the relevance of vXCL1, the DC transcription profile after infection 
with RCMV-E wt, RCMV-E vxcl1 and UV-inactivated RCMV-E was investigated 24 hpi. Due 
to the annotated genome of Rattus norvegicus published in 2014, the transcriptome of rat DC 
could be analyzed by using RNA sequencing technique. This innovative technique enables 
the examination of molecular processes within DC during RCMV-E infection or incubation at 
37°C without infection. As described above, no specific stimulus was necessary to activate 
DC since they become activated by the enrichment procedure. Because of this unspecific 
activation, freshly isolated DC with an immature phenotype were used as an input control to 
normalize the data. RNA sequencing revealed that incubation at 37°C (Mock) activates 
expression of the maturation markers CD40, CD80 and CD86, thereby proving that the 
isolation procedure indeed leads to DC maturation. The activation of CD40, CD80 and CD86 
was impaired after infection with RCMV-E. As UV-inactivated RCMV-E had no inhibitory 
effect on DC maturation markers, it can be concluded that viral replication is necessary to 
subvert DC activation and consequently to prevent DC maturation.  
A slight difference was observed between RCMV-E wt and RCMV-E vxcl1 concerning the 
expression of CD40 which was not completely inhibited by RCMV-E vxcl1 (Figure 20). 
CD40 is a member of the tumor necrosis factor receptor (TNF-R) family which activation is 
one of the critical signals that allows full maturation of DC. CD40 activation leads to several 
signal transduction pathways resulting in enhanced cell survival, cytokine secretion (IL-6, IL-
12, IL10 etc.) and finally T cell activation (Banchereau and Steinman 1998, van Kooten and 
Banchereau 2000). The fact that the presence of vXCL1 inhibits the CD40 expression 





During incubation at 37°C another maturation marker, CCR7, was upregulated. CCR7 
upregulation is critical for the guiding of migratory maturing DC to the local draining lymph 
nodes, where CCR7 ligands, including CCL19 and CCL21, are secreted. As soon as DC 
reach the lymphoid organs, antigens are presented to T cells (Braun et al. 2011, Förster et 
al. 1999, Sozzani et al. 1998). Furthermore, CCR7 regulates the organization of the actin 
cytoskeleton, enabling migration and dendritic extension which may enhance the “capturing” 
of T cells for antigen presentation (Sánchez-Sánchez et al. 2006, Yanagawa and Onoé 
2002). Interestingly, RCMV-E wt prevented the upregulation of CCR7 and this inhibition of 
CCR7 upregulation was less efficient in RCMV-E vxcl1 infected DC (Figure 20). Little is 
known about the transcriptional regulation of CCR7 though a positive regulation by NF-B 
was described earlier (Mathas et al. 2002). Binding of vXCL1 to XCR1 would activate GPCR-
adopted signaling proteins including Src family tyrosine kinases and components of the 
ERK1/2 and JNK3 MAP kinases (Luttrell and Lefkowitz 2002). In the cell signaling network 
these kinases are involved in the activation of NF-B that regulates transcription of several 
cellular proteins involved in cytokine production, cellular growth and differentiation, cell 
survival, migration and apoptosis (Grandage et al. 2005, Kopp and Ghosh 1995, Van 
Antwerp et al. 1998). It appears likely that CCR7 is only one of many factors controlled by 
NF-B. Inhibiting the expression of CCR7 would mean that RCMV-E prevents the migration 
and consequently the activation of T cells which reside in lymph nodes. Similar effects were 
reported for HHV-8 and HCMV that have inhibitory effects on CCR7 expression and thus 
subvert DC migration capacity (Cirone et al. 2012, Moutaftsi et al. 2004). 
Furthermore, expression of XCR1 was significantly reduced after infection with RCMV-E wt 
and RCMV-E vxcl1 although the absence of vXCL1 resulted in slower receptor 
internalization (Figure 15). Additionally, XCR1 expression after RCMV-E UV infection was 
reduced as well but not as rapid as in RCMV-E wt infected cells (Figure 13). This observation 
suggests that replicating and inactive virus had an influence on XCR1 internalization. The 
increased expression of IFN- and IFN- after infection with RCMV-E UV underlines the 
assumption that DC were stimulated by the viral particle itself (Supplement 3). It is possible 
that proteins from the virion surface, such as ECK-2, or tegument proteins play a notable role 
in that activation. Since XCR1 disappeared from the cell surface, RCMV-E wt and RCMV-E 
vxcl1 infected DC were not able to migrate towards recombinant rXCL1 (Figure 18). 
Apart from maturation and migration markers, genes related to antigen cross-presentation 
were influenced by RCMV-E. Rab27 and Rac2 were upregulated upon cultivation but 
downregulated after RCMV-E wt and RCMV-E vxcl1 infection. Both proteins are involved in 
the process of phagosomal protein degradation described for antigen cross-presentation. 




(NOX2), Rac2 regulates the assembly of NOX2 to the cytosolic subunits to the phagosome 
(Jancic et al. 2007, Savina et al. 2009). NOX2 prevents acidification of phagosomes, limiting 
antigen degradation and supporting cross-presentation. The absence of Rab27 and Rac2 
leads to decreased phagosomal pH resulting in enhanced proteolysis of phagocytosed 
antigens and thus impaired cross-presentation (Jancic et al. 2007, Mantegazza et al. 2008). 
Besides Rab27 and Rac2, which participate in cross-presentation, expression of Tap2 was 
reduced by RCMV-E wt and RCMV-E vxcl1 (Figure 20). Tap proteins deliver peptides to the 
ER, the place where antigens are loaded onto MHCI molecules (Suh et al. 1994).  
Due to these findings, it appears that RCMV functionally paralyzes DC by hampering 
maturation and migration to the lymphoid tissue. Furthermore, RCMV may prevent antigen 
presentation, especially cross-presentation. 
5.4 rXCL1 and vXCL1 induce internalization of XCR1 and hamper 
chemotactic activity towards rXCL1  
The XCL1-XCR1 axis appears to be an attractive target for viruses since many of them 
evolved the ability to exploit the interaction between the -chemokine and its respective 
GPCR. Kaposi sarcoma-associated herpesvirus (KSHV) encodes two β-chemokines, vCCL-2 
that acts as an antagonist and vCCL-3 that has an agonistic function on XCR1 (Lüttichau 
2008, Lüttichau et al. 2007, Nicholas 2007). Furthermore, HHV-6 encodes the β-chemokine 
receptor U51A that interacts with XCL1 (Catusse et al. 2008). RCMV-E/ -B evolved a unique 
strategy to interfere with the XCL1-XCR1 axis. The vXCL1 analogs of RCMV-E and RCMV-B 
share an amino acid identity of 83.3%. Rat XCL1 (rXCL1) is 63.2% and 65.5% identical to 
RCMV-E (vXCL1 E) and RCMV-B (vXCL1 B), respectively, and differs at the N-terminus 
which is implicated in receptor binding and activation (Clark‐Lewis et al. 1995). Indeed, 
previous studies revealed that vXCL1 and rXCL1 compete for XCR1 (Geyer et al. 2014). It 
was shown that vXCL1, compared to host rXCL1, attracts slightly higher numbers of XCR1+ 
CD4− DC and stronger activates XCR1 (Bauer et al. 2020). Upon chemokine binding and 
activation GPCR internalize, a process called desensitization. It was observed that both 
vXCL1 variants led to a stronger reduction of XCR1 surface expression compared to rXCL1 
(Figure 22). This observation supports the hypothesis that vXCL1 is a better agonist than 
rXCL1. Similar results have been reported for KSHV vCCL-3, a selective XCR1 agonist, 
whose activating potency was 10fold higher than human XCL1 (Lüttichau et al. 2007).  
Chemokine receptor activation is described by a two-step mechanism. In the first step, the 
chemokine binds to the receptor without inducing activation. This step requires the positively 
charged chemokine core which binds to the negatively charged receptor domain (Thiele and 




be facilitated by the flexible chemokine N-terminus. The core that is important for receptor 
binding is highly conserved in the vXCL1 variants as well as in rXCL1. In contrast, the N-
terminus that induces receptor activation exhibits variable sites (Figure 21). Nevertheless, 
the most striking difference between the XCL1 homologs is the high variable C-terminus with 
two additional threonines in both vXCL1 variants that exhibit glycosylation sites. This 
posttranslational modification might have an impact on receptor affinity and receptor 
activation (Geyer et al. 2014, Mortier et al. 2011). Years ago it was suggested that the C-
terminal -helix of the cell-derived factor 1 binds glycosaminoglycans which enhanced the 
biological activity of the N-terminus (Luo et al. 1999). Since it was described for MCK-2 to 
bind glycosaminoglycans (Pontejo and Murphy 2017), this might also apply to vXCL1. To 
investigate the impact of the high variable C-terminus, studies with trimmed C-termini have to 
be performed, followed by comparative activation analysis with rXCL1.  
Modifications in sequence and structure of viral homologs have likely arose during co-
evolution to perfectly adapt to their hosts. This adaptation possibly leads to a higher species 
specificity compared to host chemokines. Indeed, it was demonstrated recently that rXCL1 
crossed the species barrier by activating the human XCR1, whereas vXCL1 solely activates 
rat XCR1 (Bauer et al. 2020).  
The disappearance of XCR1 from the DC surface after ligand-binding could impede the 
communication with immune cells expressing endogenous XCL1, including NK cells, NKT 
cells and CD8+ T cells. After preincubation with vXCL1 the chemotactic activity of CD4- DC 
towards recombinant rXCL1 was abolished. As discussed before, cultured DC become 
activated which results in ligand-independent XCR1 internalization. Hence, the chemotactic 
activity of untreated DC towards rXCL1 was reduced as well (Figure 23). Internalization of 
XCR1 appears to be a part of the DC maturation process. Matured DC change their function 
from patrolling and taking up antigens and are recruited directly to lymphoid organs where 
antigens are presented to T cells (Alloatti et al. 2016). To successfully complete antigen 
presentation, XCR1 expression has to be reduced, otherwise DC would be attracted to 
another site of inflammation. In the context of vXCL1, XCR1+ rat DC, assumed to cross-
present antigens, would be attracted to the site of RCMV infection. RCMV infection induces 
functional paralysis of DC, possibly resulting in impaired antigen presentation. This strategy 
might be key to exclude cross-presenting DC from immune cell communication and 




5.5 Infection of Xcr1-/- and Xcr1+/+ rats 
5.5.1 XCR1 is dispensable for RCMV-B spread 
70 years ago, Frank Fenner et al. were the first to describe virus dissemination on the basis 
of Mousepox infection. They proposed a two-step dissemination model with a primary 
viremia in liver and spleen followed by secondary viremia causing dissemination throughout 
the body (Fenner 1949). This model of dissemination got widely accepted for many viruses, 
including CMV with salivary glands being secondary infection sites (Collins et al. 1994). i.p. 
infection with RCMV-B revealed high titers in liver and spleen 5 dpi (Figure 24) which was in 
line with i.p. infected MCMV and RCMV-M (Bruggeman et al. 1985, Collins et al. 1994). 
However, recent studies demonstrated that the colonization of spleen and liver appears only 
after i.p. or i.v. injection that do not represent natural routes of CMV infection but occur as a 
result of the interception of cell-free virions by local macrophages (Farrell et al. 2017, 
Frederico et al. 2014). In contrast, an olfactory inoculation with MCMV which parallels a 
natural CMV infection route was shown to omit infection of liver and spleen (Farrell et al. 
2019, Sacher et al. 2011). Moreover it was shown that MCMV reaches salivary glands via 
DC after both i.p. and olfactory infection (Farrell et al. 2019). This suggests that the virus 
directly attracts DC to the site of infection regardless of the infection route.  
Since RCMV-E and RCMV-B exclusively attract XCR1+ DC it remained to be investigated 
whether XCR1 is necessary for viral spread. In accordance to i.p. infection with MCMV, 
RCMV-M and RCMV-E, viral DNA of RCMV-B was identified in liver and spleen 5 dpi (Figure 
24) (Bruggeman et al. 1985, Collins et al. 1994, Sandford et al. 2001). Interestingly, at that 
time point more gB copies could be detected in lung and salivary glands of Xcr1+/+ rats, 
suggesting that XCR1 has an impact on the pace of RCMV-B spread (Figure 24).16 dpi viral 
DNA as well as infectious RCMV-B could be determined in salivary glands with no significant 
difference between Xcr1-/- and Xcr1+/+ rats. However, two Xcr1+/+ rats had greater viral titers 
whereas two Xcr1-/- rats showed much lower titers (Figure 25). Considering that CMV 
disseminates through blood (Collins et al. 1994), the high RCMV-B titers in salivary glands 
were probably supported by a high rate of blood flow through the glands which is achieved 
by an abundant capillary supply (Lü and Jacobson 2007). Since these experiments provides 
only indications for XCR1 being necessary for RCMV to reach the salivary glands, this issue 




5.5.2 RCMV-B infection leads to migration of DC, B cells, CD8+ T cells, NK and NKT 
cells in primary infected organs 
In order to get an overview of immune cell migration during RCMV-B infection and to 
determine the role of XCR1 in immune cell communication, cells from innate and adaptive 
immune system were analyzed in blood, spleen, lymph nodes and salivary glands at different 
time points post infection. Whereas virus detection failed at 3 dpi, a response could be 
determined on the cellular level (Figure 26). In spleen, the place of primary infection, higher 
frequencies of NK cells, NKT cells and CD8+ T cells were observed. In addition, the 
frequency of CD8+ T cells was reduced in lymph nodes while the frequency of DC was 
slightly elevated. This leads to the presumption that the innate immune system recognized 
the virus in a very early phase, followed by activation of the adaptive immune system in 
lymph nodes which led to the migration of CD8+ T cells to the site of infection. This kind of 
bridging is facilitated by DC (Banchereau et al. 2000). According to the elevated viral load in 
spleen, frequencies of NK cells and NKT cells were increased as well two days later. In 
contrast, DC and B cell frequency was reduced in spleen. Since activated B cells generated 
in spleen migrate to the bone marrow this could lead to a reduced frequency of B cells in 
spleen after infection and might indicate that adaptive immunity is activated by 5 dpi. 
Furthermore, antigen-bearing DC could leave the spleen to migrate to lymph nodes where 
ingested antigens are presented. Surprisingly, higher amounts of NK and NKT cells were 
detected in lymph nodes, leading to the presumption that RCMV colonizes these organs as 
well. Indeed, Farrell et al. demonstrated that MCMV-infected DC reach the blood via lymph 
nodes (Farrell et al. 2017). Moreover, it has been suggested that the main location of NK-DC 
interactions might be sites of inflammation and lymph nodes (Cooper et al. 2004). 
Unfortunately, lymph nodes from Xcr1+/+ and Xcr1-/- rats were not investigated for RCMV 
infection.  
5.5.3 RCMV-B infection leads to increased frequency of DC, CD8+ T cells, NK cells 
and NKT cells in the salivary glands 
After 16 dpi RCMV-B was detected in salivary glands. Salivary glands represent a very 
attractive site for the virus to become latent since reactivation would pour out virions into the 
saliva followed by smear transmission, even though no oral target cells have been identified 
to date (Farrell et al. 2019). Besides the determination of viral titers, the immune cells that 
migrated to salivary glands after infection were examined. As expected, higher amounts of 
NK cells and NKT cells were found. Compared to Xcr1-/- rats, more NK cells and NKT cells 
were found in salivary glands and blood of Xcr1+/+ rats. Mostly interesting was that also the 
frequency of DC was higher in Xcr1+/+ salivary glands which corresponded to the chemotaxis 




(Figure 11). This again raised the question whether there is another chemokine or 
chemokine receptor encoded by RCMV that attracts DC to the site of infection. Furthermore, 
strong elevated amounts of CD8+ T cells were determined in salivary glands. NK cells, NKT 
cells as well as CD8+ T cells were shown to produce XCL1 after stimulation ex vivo (Figure 
10). Therefore, these cells might reach the salivary glands first where they secrete XCL1 to 
attract XCR1+ DC. This scenario could explain why the attraction of DC in Xcr1-/- rats was not 
as successful as in Xcr1+/+ rats (Figure 29). Paradoxically, the absence of XCR1 influences 
the migration of NK cells and NKT cells to the salivary glands as well. In contrast, the 
frequency of CD8+ T cells has trebled after infection, regardless of XCR1 expression. The 
rapidity with which viral spread and immune cell migration occurs makes intermediate events 
hard to capture. To gain a more complete picture of the immunological processes caused by 
RCMV-B, time points should be chosen in a 24 h rhythm.  
Furthermore, only in Xcr1+/+ rats the frequency of CD8+ T cells remained elevated at 90 dpi 
(Figure 30). In MCMV infected mice, primed CD8+ T cells could be isolated from salivary 
glands. Nevertheless, in spite of the adaptive cytotoxic immune response, MCMV could not 
be eliminated from the host (Campbell et al. 2008). These data correspond to our findings, 
since still low ratios of RCMV-B DNA could be determined after 90 dpi (Figure 24).  
In contrast to CD8+ T cells, the amount of CD4+ T cells remained unchanged during infection 
(Supplement 11). However, CD4+ T cells are known to play a role in clearing replicating 
MCMV in later phases of infection (Cavanaugh et al. 2003, Holtappels et al. 2008, Jonjić et 
al. 1990).  
Taken together, XCR1 seems to impact the pace of viral dissemination and plays a role in 
the attraction of cytotoxic innate immune cells and the maintenance of cytotoxic adaptive 
immune cells in the salivary glands. 
5.6 vXCL1 plays a pivotal role in RCMV-B dissemination and immune 
cell migration 
To examine the role of vXCL1 on viral dissemination, a vxcl1 deletion mutant of RCMV-B 
was generated to perform functional analysis of vXCL1 in vivo. The deletion mutant contains 
an insertion of cytosine at position 161 of b156.5 (vxcl1) which leads to a frameshift and a 
premature stop codon. Whereas vxcl1 mRNA is transcribed in RCMV-B vxcl1 (data not 
shown), no vXCL1 protein is being secreted (Figure 31). Interestingly, vXCL1 could still be 
intracellularly shown in RCMV-B vxcl1 infected REF (Figure 31), suggesting that the 
antibody recognizes an epitope among the first 60 amino acids which are still produced. 




RCMV-B vxcl1 infected REF, it can be concluded that the shortened protein is not secreted 
and is likely degraded by the cellular proteasome. In addition, loss of function was confirmed 
by chemotaxis assay where supernatants of RCMV-B vxcl1 infected REF were unable to 
attract XCR1+ DC (Kelch 2020).  
To analyze the function of vXCL1 in vivo, Lewis rats were infected with RCMV-B wt and 
RCMV-B vxcl1. To monitor viral access to the salivary glands, animals were analyzed at 16 
dpi. In contrast to XCR1-deleted animals where RCMV-B infection had no influence on viral 
DNA loads, the absence of vXCL1 showed greatly reduced viral DNA loads in spleen, liver, 
lung and especially salivary glands. Titration of salivary glands on REF revealed that RCMV-
B vxcl1 scarcely formed plaques (Figure 32). Therefore, it can be assumed that the virus 
did not reach the salivary glands. Ex vivo reactivation experiments at 16 dpi underlined these 
findings and demonstrated that RCMV-B wt could be reactivated already 4-6 days post organ 
removal whereby RCMV-B vxcl1 reactivated first after 15-28 days (Kelch 2020). Possibly, 
the deletion mutant could have been defeated by the innate and adaptive immune cells at an 
earlier time point. Indeed, in spleen elevated frequencies of NK cells, NKT cells and CD8+ T 
cells were determined (Figure 33). However, the number of these cell populations in the 
spleen of RCMV-B vxcl1 infected rats was lower. This supports the idea that the absence of 
vXCL1 hampers viral transport to the spleen. Alternatively, if replicating virus had been 
successfully cleared by immune cells, the immune response could have been abated after 16 
days of infection. Those questions remain to be investigated.  
In line with data obtained from infection experiments in Xcr1-/- rats the frequency of NK cells 
and NKT cells was significantly less elevated in salivary glands of RCMV-B vxcl1 compared 
to RCMV-B wt infected Xcr1+/+ rats. However, whereas the absence of XCR1 had no 
significant influence on viral load in salivary glands, the lower frequency of NK cells and NKT 
cells was accompanied with lower titers of RCMV-B vxcl1. According to data obtained from 
infected Xrcr1-/- rats, the absence of vXCL1 resulted in reduced DC migration to salivary 
glands of infected rats. Thus, vXCL1-XCR1 communication appears to be necessary for DC 
to migrate to the salivary glands after RCMV-B infection. Furthermore, the lower frequency of 
DC was consistent with lower RCMV-B vxcl1 titers. It was striking that the migration of CD8+ 
T cells to the salivary glands was almost undetectable when vXCL1 was not present. This 
stands in contrast to results obtained with the XCR1 knockout rat where no reduced CD8+ T 
cell migration was observed. T cells become attracted by several chemokines, including 
CCL5 (RANTES) (Hidi et al. 2000) that are produced by monocyte-derived DC and NKT cells 
in inflamed tissue (Faunce and Stein-Streilein 2002, Zhu et al. 2000). On the basis of the low 




The lower frequencies of immune cells in salivary glands of RCMV-B vxcl1 infected rats 
appear to be a consequence of impaired viral dissemination due to the absence of vXCL1.  
In conclusion, vXCL1 is indispensable for successful dissemination of RCMV-B. However, 
the mechanism resulting in failure of viral dissemination needs further investigation. Three 
possibilities can be imagined: 1) vXCL1 is needed to attract DC which are used to reach the 
spleen; 2) vXCL1 attracts DC to the spleen and RCMV infects them for productive 
amplification; 3) Viral replication occurs in other cells of the spleen which secrete vXCL1 
attracting DC. Attracted DC could become infected by RCMV and be used as a transport 
vehicle to reach the salivary glands.  
Besides all these indications, it still remains to be examined whether RCMV uses DC as a 
transport vehicle to reach salivary glands. Unfortunately, the detection of IE1 in salivary 
gland DC failed (data not shown). However, if RCMV reaches salivary glands using XCR1+ 
DC as a vehicle, the question arises how DC become manipulated by RCMV to reach the 
site of secondary infection. What are the molecular mechanisms to misdirect a cell? The 
capacity of DC to migrate first to the site of infection and then to the draining lymph nodes is 
crucial for their function. Basically, cell recruitment occurs in response to stimuli like type 1 
IFN and chemokines that interact with specific chemokine receptors (Biron et al. 1999). 
Immature DC express receptors including XCR1, CCR1, CCR2 and CCR5 which enable 
migration to inflamed tissue where XCL1, CCL5/RANTES, CCL4, CCL3 and CCL2 are 
secreted (Dorner et al. 2004, Frascaroli et al. 2006). Upon DC maturation the inflammation-
associated chemokine receptors (CCR1, CCR5 and CCR6) are downregulated whereas 
CCR7-mediated migration to the lymph nodes is upregulated (Sallusto et al. 1999). The 
RCMV-E-induced inhibition of CCR7 upregulation is one possibility how migration routes of 
DC could be changed. In that regard, HCMV was shown to downregulate CCR1 and CCR5 
in infected DC which suggests another strategy to influence DC migration (Varani et al. 
2005). 
5.7 Proposed model of RCMV interference with the XCL1-XCR1 axis in 
vivo 
Many data have been published on CMV infection, dissemination and immune evasion 
strategies (Farrell et al. 2019, Miller-Kittrell and Sparer 2009, Mocarski et al. 2013). However, 
RCMV-E and RCMV-B are the only known viruses to encode the -chemokine homolog 
vXCL1 (Geyer et al. 2014). Thus, RCMV-B and RCMV-E evolved an exclusive strategy to 
explicitly interact with XCR1+ DC that are the only known cells to cross-present antigen 
(Bachem et al. 2010, Bachem et al. 2012). The data presented in this work are divided in an 




In ex vivo experiments it was demonstrated that RCMV-B chemoattracts solely CD4- DC. At 
first glance, it might not be beneficial for the virus to attract a powerful antigen presenting cell 
subset. However, in ex vivo infections it was revealed that RCMV-E is able to infect and 
successfully replicate in DC. RCMV-E infection induced downregulation of maturation 
markers and changed the migration behavior towards rXCL1. Furthermore, genes related to 
antigen presentation were downregulated. These findings are in line with studies of MCMV 
infected DC (Andrews et al. 2001). vXCL1 had no influence on the infection and replication 
ex vivo, suggesting that vXCL1 exerts exclusively an in vivo function that cannot be 
investigated ex vivo. Nevertheless, RNA sequencing of infected DC revealed slight 
differences between RCMV-E wt and RCMV-E vxcl1 in the expression of several genes 
including CD40 and CCR7. The activation of XCR1 and the following signaling cascade 
might be involved in the regulation of the respective genes.  
Since CD4- DC of Xcr1-/- rats were still attracted by supernatants of RCMV-B-infected REF 
the question arose whether there might be another viral chemokine that influences this 
respective cell population. To investigate XCR1 and vXCL1 independently, Xcr1-/- rats were 
infected with RCMV-B wt and wild type rats were infected with a RCMV-B vxcl1 deletion 
mutant. Whereas deletion of XCR1 has an impact on the pace of RCMV dissemination, the 
absence of vXCL1 led to an almost completely prevention of dissemination. This underlines 
the idea, that vXCL1 might act through another surface-protein or –molecule expressed on 
CD4- DC. To date there is no evidence that vXCL1 has another interaction partner, though it 
is known for viruses to encode promiscuous chemokines as well as chemokine binding 
proteins (Murphy 2001, Thiele and Rosenkilde 2014). The HCMV chemokine binding protein 
pUL21.5 binds CCL5/RANTES, blocking the interaction with its cellular receptor (Wang et al. 
2004). The question whether vXCL1 has another interaction partner, including host 
chemokines, requires further investigations. 
MCMV does not encode vxcl1, but it was demonstrated that M33, a viral chemokine receptor, 
and MCK-2 ensure infection of DC and myeloid progenitor cells, respectively, and delivery of 
viral particles to salivary glands (Farrell et al. 2019, Jordan et al. 2011, Noda et al. 2006). 
The HCMV homolog UL33 was shown to heterodimerize with CCR5 and CXCR4 which 
facilitates the interaction with DC (Tadagaki et al. 2012). Since disrupting the GPCR homolog 
of RCMV-M (R33) also reduces infection of salivary glands (Beisser et al. 1998b), a 
conserved function can be assumed for RCMV-E E33 and RCMV-B B33. However, Farrell et 
al. did not exclude that random DC migration could also initiate salivary gland infection 
(Farrell et al. 2017, Farrell et al. 2019). An infection of randomly migrated DC would be 
unlikely for RCMV-E and RCMV-B since they encode a chemokine that exclusively attracts 




Most of investigated CMV species are known to infect many other cells than DC including 
granulocytes, monocytes and endothelial cells (Revello and Gerna 2010) which were all 
shown to facilitate CMV dissemination (Sacher et al. 2011, van der Strate et al. 2003). Since 
CMV has a broad cell tropism, it is possible that CMV uses more than one cell population to 
reach their shedding site. However, this would mean that CMV must have an accurate time 
management to evade the immune responses.  
In terms of viral time management, a model is proposed of how RCMV-B and immune cells 
could interact with each other. Early post infection high numbers of innate immune cells (NK 
cells and NKT cells) were found at sites of RCMV-B infection. The attraction to the site of 
infection could have been mediated by resident DC and other cell types that produce 
cytokines and chemokines as a response to infection (Cooper et al. 2004, Lande et al. 2003). 
During infection activated NK cells produce a number of cytokines and chemokines that 
attract patrolling DC to the inflamed tissue (Moretta 2002). These chemokines include XCL1 
that attracts XCR1+ DC. During RCMV infection, XCR1+ DC could be attracted by vXCL1 
before DC encounter NK cell-secreted XCL1. After becoming infected, DC chemotaxis could 
have been induced by different chemokines including CCL4, CCL5, CCL22 (Cooper et al. 
2001, Robertson 2002). RCMV could then reprogram DC by suppressing the transcription of 
chemokine receptors, e.g., CCR7 which would prevent migration to lymph nodes and 
activate other receptors that support migration to salivary glands. Following the infection of 
salivary glands by DC one could assume that CD8+ T cells, previously primed in the lymph 
nodes, reach the site of secondary infection. In addition, migration and maybe even the 
priming of CD8+ T cells was driven by high viral titers. When RCMV-B vxcl1 dissemination 
was reduced, CD8+ T cells were hardly detected in salivary glands. In contrast, the frequency 
of CD8+ T cells was only slightly reduced in spleen after RCMV-B vxcl1 infection (Figure 
33), leading to the assumption that the deletion mutant was cleared by recruited CTL in the 
spleen. Interestingly, although primed CD8+ T cells could be found in MCMV-infected salivary 
glands, the virus could not be cleared from the tissue and MCMV became latent (Campbell et 
al. 2008). These findings correspond to RCMV-B wt whose DNA was still detectable at 90 dpi 
(Figure 24). Unfortunately, it still cannot be definitely answered how CMV hides from the 
immune response.  
In conclusion, the proposed model in Figure 34 demonstrates that migration of immune cells 
to infection sites is temporally separated. It is suggested that RCMV-B vXCL1 attracts XCR1+ 
DC before the latter become attracted by NK cell-secreted XCL1. As part of the second 
phase of infection, eventually infected DC become enticed by NK cells and NKT cells in 
salivary glands. Finally, primed CD8+ T cells get lured to the site of secondary infection. In 




reduced recruitment of immune cells to the salivary glands. This model suggests that vXCL1 
plays a crucial role for DC attraction and dissemination to the salivary glands.  
 
Figure 34: Proposed model of the interplay between RCMV and immune cells. 1. Following an i.p. infection 
RCMV disseminates to the spleen (primary infection). 2. XCR1+ DC are attracted by vXCL1 before NK cells, NKT 
cells and CD8+ T cells co-localize with RCMV in the spleen and secrete XCL1. 3. Infected XCR1+ DC are used as 
a transport vehicle to reach the salivary glands. 4. NK cells and NKT cells are recruited to infected salivary 
glands. Infected DC reach salivary glands followed by the attraction of primed CD8+ T cells. Although innate and 
adaptive immune cells are alarmed, RCMV replication is not halted and the virus achieves latency. 
5.8 Conclusion 
The two MuHV-8 isolates RCMV-B and RCMV-E are the only known viruses that encode the 
-chemokine vXCL1 (Geyer et al. 2014). Since CMV is strict species-specific, rats were used 
as an animal model to analyze RCMV infection and vXCL1 functionality. However, most of 
immunological studies were conducted in the mouse model. Comparisons between species 
have to be made with caution since cell phenotypes and functions differ for similar occurring 
cell populations (Yrlid and Macpherson 2003). The same applies to comparisons between 
CMV species (Rölle and Olweus 2009). Due to millions of years of co-evolution the immune 
response has adjusted to immune-modulating viruses. It is speculated that MCMV and 
RCMV originated from a common progenitor but evolved differently during the separation of 
mouse and rats millions of years ago. Therefore, it is obvious that both virus species evolved 
different strategies to subvert their host’s immune response. Nevertheless, both species 
appear to target DC (Farrell et al. 2017, Geyer et al. 2014). Actually, DC can be infected by a 




rather a strategy by the host, promoting antiviral cytotoxic T cell response (Freigang et al. 
2005). However, during the long-lasting co-evolution CMV evolved many strategies to 
subvert this response. The “cat-and-rat” game between the immune response and CMV 
could improve evading mechanisms of the virus. On the contrary, it could induce the 
development of new immune response strategies to fight the virus. This would mean that the 






To date, the two Rat Cytomegalovirus (RCMV) isolates RCMV-England (RCMV-E) and 
RCMV-Berlin (RCMV-B) are the only known viruses that encode a homolog of XCL1, a -
chemokine adopted by viral piracy to interfere with the host’s chemokine network. Like its 
host homolog, vXCL1 exclusively attracts dendritic cells (DC) that express the XC chemokine 
receptor 1 (XCR1). 
In this work, it was investigated whether RCMV misuses the XCL1-XCR1 axis to infect DC in 
order to disseminate within the host. Initially, rat DC phenotyping revealed two major DC 
populations, XCR1+ CD4- DC and XCR1- CD4+. It could be shown that supernatants of 
RCMV-infected rat embryonic fibroblasts solely attracted the XCR1+ CD4- population. 
Moreover, RCMV was able to infect and replicate in DC.  
Due to digestion of the spleen and leukocyte enrichment DC became activated leading to full 
maturation 24 h after cell isolation. During infection, RCMV inhibited the upregulation of 
several maturation markers including CD40, CD86 and CCR7 and also led to reduced 
expression of MHCII, CD4 and XCR1. Regardless of vXCL1, RCMV appears to paralyze DC 
functionality by downregulating maturation genes.  
In order to analyze the role of XCR1 and vXCL1 function in vivo, Xcr1+/+ and Xcr1-/- rats were 
infected with RCMV-B wt and RCMV-B vxcl1. Whereas the XCR1 expression level had an 
influence on the pace of RCMV-B wt dissemination to the salivary glands, the absence of 
vXCL1 led to a strong decrease in viral spread. DC migration to the salivary glands was 
dependent on vXCL1 as well as XCR1 and was markedly reduced when vXCL1 and XCR1 
were not present. During infection, CD8+ T cells were recruited to the salivary glands, 
however, this migration was missing when Xcr1+/+ rats were infected with RCMV-B vxcl1.  
In conclusion, RCMV has the ability to infect DC regardless of vXCL1 expression. RCMV 






Bis heute sind die beiden Ratten-Cytomegalovirus (RCMV)-Isolate RCMV-England (RCMV-
E) und RCMV-Berlin (RCMV-B) die einzig bekannten Viren, die ein Homolog von XCL1 
kodieren, einem -Chemokin, das vom Virus kopiert wurde um das Chemokin-Netzwerk des 
Wirts zu beeinträchtigen. Wie das Wirtshomolog lockt vXCL1 ausschließlich dendritische 
Zellen (DC) an, die den XC-Chemokinrezeptor 1 (XCR1) exprimieren. 
In dieser Arbeit wurde untersucht, inwieweit RCMV die XCL1-XCR1-Achse nutzt, um DC zu 
infizieren und sich im Wirt auszubreiten. Durch die Phänotypisierung von Ratten-DC konnten 
zwei Hauptpopulationen identifiziert werden, XCR1+ CD4- und XCR1- CD4+ DC. Es konnte 
gezeigt werden, dass Überstände von RCMV-infizierten embryonalen Rattenfibroblasten 
ausschließlich die XCR1+ CD4- Population anlocken. Darüber hinaus konnte nachgewiesen 
werden, dass RCMV DC infiziert und in diesen repliziert.  
Durch den Verdau der Milz und die Leukozyten Anreicherung wurden die DC aktiviert, was 
zu einer vollständigen Reifung 24 h nach der Zell Isolierung führte. Während der Infektion 
inhibierte RCMV die Hochregulation mehrerer Reifungsmarker, einschließlich CD40, CD86 
und CCR7 und führte zu einer verringerten Expression von MHCII, CD4 und XCR1. 
Unabhängig von vXCL1 scheint RCMV die DC-Funktionalität durch das Herunterregulieren 
von Reifungsgenen zu lähmen.  
Um die Rolle von XCR1 und die Funktion von vXCL1 in vivo zu analysieren, wurden Xcr1+/+ 
und Xcr1-/- Ratten mit RCMV-B wt und RCMV-B vxcl1 infiziert. Während das XCR1-
Expressionsniveau einen Einfluss auf die Geschwindigkeit der RCMV-Verbreitung in den 
Speicheldrüsen hatte, führte das Fehlen von vXCL1 zu einer starken Abnahme der 
Virusausbreitung. Die DC-Migration in die Speicheldrüsen war sowohl von vXCL1 als auch 
von XCR1 abhängig und war deutlich reduziert, wenn vXCL1 und XCR1 nicht vorhanden 
waren. Während der Infektion wurden CD8+ T-Zellen in die Speicheldrüsen rekrutiert. Diese 
Migration blieb jedoch aus, wenn Xcr1+/+ Ratten mit RCMV-B vxcl1 infiziert wurden. 
Zusammenfassend besitzt RCMV die Fähigkeit DC unabhängig von der vXCL1-Expression 
zu infizieren. RCMV verwendet vXCL1, um XCR1+ DC anzulocken, was entscheidend für die 
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Supplement 1: CD4- DC express higher amounts of CD103.  Rat spleen was digested with Collagenase D and 
Dnase I followed by OptiPrep density centrifugation. DC were gated by excluding dead, CD3+ and CD45RA+ cells. 
Two major DC subsets were differentiated by the expression of CD4 and XCR1. XCR1+ CD4- population (pink 
color) and XCR1- CD4+ population (green color) were then gated back into MHCII and CD103 plot to demonstrate 





Supplement 2: Heatmap of differentially expressed genes of infected DC. Ox-62 enriched DC were infected 
with RCMV-E wt, UV-inactivated RCMV-E and RCMV-E vxcl1. Mock-infected cells served as negative control. 
Expressed genes were normalized to freshly isolated, not cultivated DC. Designated as red are upregulated and 
as blue downregulated genes. Differentially expressed genes predicted by SCORE with Fold Change > 4, p ≤ 





Supplement 3: Heatmap of differentially expressed cytokines of infected DC. Ox-62 enriched DC were 
infected with RCMV-E wt, UV-inactivated RCMV-E and RCMV-E vxcl1. Mock-infected cells served as negative 
control. Expressed genes were normalized to freshly isolated, not cultivated DC. Designated as red are 
upregulated and as blue downregulated genes. Differentially expressed genes predicted by SCORE with Fold 





Supplement 4: Heatmap of differentially expressed genes of interest of infected DC. Ox-62 enriched DC 
were infected with RCMV-E wt, UV-inactivated RCMV-E and RCMV-E vxcl1. Mock-infected cells served as 
negative control. Expressed genes were normalized to freshly isolated, not cultivated DC. Designated as red are 
upregulated and as blue downregulated genes. Differentially expressed genes predicted by SCORE with Fold 





Supplement 5: Dotplots and gating of enriched leukocytes from blood, lymph nodes, salivary glands and 
spleen. 10-week-old male rats were infected with 1*106 pfu of RCMV-B. After 3, 5, 16 and 90 days post infection, 
blood, lymph nodes, salivary glands and spleen were collected and processed for cell isolation. A) Cells were 
stained to analyze DC (MHCII+ CD103+) and B cells (CD45RA+). B) Cells were stained to analyze T cells (CD3+), 






Supplement 6: NK cell population within living cells. 10-week-old male Sprague Dawley rats were infected 
with 1*106 pfu of RCMV-B. Leukocytes were isolated from blood, lymph nodes, salivary glands and spleen. After 
surface staining, cells were gated on CD161+ and CD3- to analyze NK cells. Frequency of CD161+ CD3- cells 
within living cells is shown. Error bars represent mean ± SD, n = 6 rats. 
 
 
Supplement 7: NKT cell population within living cells. 10-week-old male Sprague Dawley rats were infected 
with 1*106 pfu of RCMV-B. Leukocytes were isolated from blood, lymph nodes, salivary glands and spleen. After 
surface staining, cells were gated on CD161+ and CD3+ to analyze NKT cells. Frequency of CD161+ CD3+ cells 






Supplement 8: Frequency of DC population within living cells. 10-week-old male Sprague Dawley rats were 
infected with 1*106 pfu of RCMV-B. Leukocytes were isolated from blood, lymph nodes, salivary glands and 
spleen. After surface staining, cells were gated on MHCII+ and CD103+ to analyze dendritic cells. Frequency of 
CD103+ MHCII+ cells within all living cells is shown. Error bars represent mean ± SD, n = 6 rats. 
 
 
Supplement 9: Frequency of B cell population within living cells. 10-week-old male Sprague Dawley rats 
were infected with 1*106 pfu of RCMV-B. Leukocytes were isolated from blood, lymph nodes, salivary glands and 
spleen. After surface staining, cells were gated on CD45RA+ and MHCII+ to analyze B lymphocytes. Frequency of 





Supplement 10: Frequency of CD8+ T cell population within T cells. 10-week-old male Sprague Dawley rats 
were infected with 1*106 pfu of RCMV-B. Leukocytes were isolated from blood, lymph nodes, salivary glands and 
spleen. After surface staining, cells were gated on CD3+ and CD8+ to analyze cytotoxic T cells. Frequency of 
CD3+ CD8+ cells within T cell population is shown. Error bars represent mean ± SD, n = 6 rats. 
 
 
Supplement 11: Frequency of CD4+ T cell population within T cells. 10-week-old male Sprague Dawley rats 
were infected with 1*106 pfu of RCMV-B. Leukocytes were isolated from blood, lymph nodes, salivary glands and 
spleen. After surface staining, cells were gated on CD3+ and CD4+ to analyze helper T cells. Frequency of CD3+ 
CD4+ cells within T cell population is shown. Error bars represent mean ± SD, n = 6 rats. 
 
 
 
 
